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ABSTRACT 
Barthelemy, Joanna Ph.D., Biomedical Sciences Ph.D. program , Wright State University, 
2015. A novel function for FANCJ helicase in microsatellite stabilization during 
replication stress. 
Noncanonical DNA structure-forming sequences, such as hairpin structures, stall 
replication forks in vivo, expand or contract during DNA replication, and colocalize with 
chromosome fragile sites. Since the frequency of hairpin formation is higher than the 
frequency of expansion or contraction, the cell may possess mechanisms to resolve 
hairpin structures prior to replication fork stalling. One possible activity for hairpin 
resolution is the FANCJ DNA helicase, known to unwind noncanoncial DNA structures 
in vitro. Indeed, mutations or loss of any of the nineteen FANC genes, including FANCJ, 
leads to genome instability and the cancer-prone syndrome Fanconi anemia (FA).  
To test whether (CTG)n·(CAG)n trinucleotide repeat (TNR) stability is protected 
by FANCJ in human cells, HeLa derived cell lines were created by integration of 
cassettes containing the c-myc replication origin and (CTG)n · (CAG)n TNRs. Small pool 
PCR was used to assess genome instability after siRNA depletion of FANCJ helicase in 
the presence of a replication stress. The results of these experiments indicate FANCJ 
helicase is essential for the maintenance of (CTG)n·(CAG)n TNR stability independent of 
replication polarity, and DNA double strand breaks (DSBs) occur near (CTG)n·(CAG)n 
microsatellites in the absence of FANCJ helicase. These results were confirmed in FA 
patients cells null for FANCJ. Remarkably, several other types of microsatellite 
sequences capable of forming noncanoncial DNA structures (hairpins, triplexes, G-
quadruplexes, unwound DNA) also suffered DSBs in FANCJ depleted cells, indicating a 
novel role for FANCJ in microsatellite stabilization across the genome. In contrast, HeLa 
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cells depleted for other FANC proteins or patient cells null for other FA proteins did not 
show a similar phenotype suggesting FANCJ stabilizes microsatellite sequences apart 
from activation of the FA repair pathway. 
Genome instability present at microsatellite sequences results in loss of small pool 
PCR signal leading us to believe double strand break formation has occurred. We suspect 
loss of PCR signal results from unrepaired DSBs or DSBs repaired by a translocation 
event to another site along the genome. To understand the mechanism of double strand 
break repair at the ectopic site (CTG)·(CAG) trinucleotide repeats, determined by small 
pool PCR signal loss, inverse PCR coupled with next generation sequencing was 
employed. The results of next generation sequencing revealed that DSBs are occurring at 
or near the (CTG)·(CAG) repeats of the ectopic site in cells depleted of FANCJ and 
treated with aphidicolin lead to translocations with other sites along the genome. Next 
generation sequencing identified chromosomal positions of translocation sites. These 
chromosomal positions correspond to cytogenetic positions which have previously been 
identified as being associated with chromosome breaks in tumors and cells from patients 
with several developmental disorders. These results suggest a role for FANCJ helicase in 
cancer and other developmental diseases as a protector of microsatellite stability. 
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INTRODUCTION 
(CTG)·(CAG) trinucleotide repeats are dynamic DNA sequences 
Microsatellites, short repetitive DNA sequences (such as (CTG)·(CAG) repeats), 
are prone to form noncanonical DNA structures such as hairpins, triplexes, and G-
quadruplexes when DNA is in a single strand conformation (Figure 1) (Collins et al., 
2003; Cooper et al., 2011; Gatchel and Zoghbi, 2005; McMurray, 2010). These structures 
pose a threat to proper DNA replication, represent hotspots for chromosomal breakage 
and translocations, and increase the potential for genome instability (Cooper et al., 2011; 
Gatchel and Zoghbi, 2005; McMurray, 2010; Zeman and Cimprich, 2014). During DNA 
metabolism, the structure forming sequence is exposed after unwinding from histones 
leading to the formation of non-B DNA structures. The noncanonical DNA structure is 
susceptible to DNA damage and evades DNA repair mechanisms resulting in 
accumulation of DNA damage (Aguilera and Gomez-Gonzalez, 2008; Glover et al., 
1984; Wang and Vasquez, 2009). Models for noncanonical DNA structures to 
accumulate double strand breaks during replication are depicted in Figure 2 (Aguilera and 
Gomez-Gonzalez, 2008; Glover et al., 1984).  Expansion or contraction in the number of 
repeats of the microsatellite and formation of double strand breaks at or near the 
repetitive sequence represent consequences of noncanoncial DNA structure formation 
and are termed instability (Zeman and Cimprich, 2014). All forms of repeat instability 
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threaten genomic integrity. Genomic aberrations caused by instability of microsatellites 
are associated with multiple human diseases.  
(CTG)·(CAG) repeat instability association with DM1 
(CTG)·(CAG) trinucleotide repeats are one subset of microsatellite sequences. 
(CTG)·(CAG) repeat instability has been linked to multiple neurodegenerative disorders 
including myotonic dystrophy type1. Myotonic dystrophy type 1 (DM1) refers to a 
chronic, systemic disorder affecting approximately 1 in 8,000 individuals worldwide 
(Shaw and Harper, 1989). Characteristics of DM1 include muscle wasting, myotonia 
(prolonged muscle contractions), cataracts, heart conduction defects, and weakness in the 
extremities and face (Shaw and Harper, 1989). The cause of DM1 has been linked to an 
expansion of a (CTG)·(CAG) microsatellite, a short repeated DNA sequence, in the 
dystrophia myotonica protein kinase (DMPK) gene (Fernandez-Lopez et al., 2004; 
McMurray, 2010). (CTG)·(CAG) repeat lengths are categorized into three classes: 
normal range (5-37 repeats), pre-mutation (38-49 repeats), and symptomatic disease (≥50 
repeats). In affected individuals there is a direct correlation between the length of the 
(CTG)·(CAG) repeats and severity of the disease, and an inverse correlation with the age 
of disease onset, termed genetic anticipation. The (CTG)·(CAG)repeats are located in the 
3’ untranslated region (3’ UTR) of the DMPK gene (Brook et al., 1992). An expansion in 
the (CTG)·(CAG) repeats leading to a disease state and the observed phenotypes results 
from an accumulation of unprocessed messenger RNA (mRNA) in the nucleus (Roberts 
et al., 1997). The large number of (CTG)·(CAG) repeats transcribe into CUG repeats 
(Brook et al., 1992; Tiscornia and Mahadevan, 2000). These CUG repeats sequester 
splicing proteins, specifically musclebind like protein (MBNL), affecting the proper 
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processing of other pre-mRNAs (Tiscornia and Mahadevan, 2000). Recent research 
suggests prevention of proper mRNA processing through altered MBNL levels directly 
correlates to myotonia, muscle wasting, and cardiac abnormalities seen in DM1 patients 
(Orengo et al., 2008).  
Our laboratory previously showed the (CTG)·(CAG) repeats responsible for DM1 
form hairpin structures in vivo (Liu et al., 2010). Replication forks move slower and hold 
a greater tendency to stall at fragile sites, such as (CTG)·(CAG) repeats (Freudenreich et 
al., 1997; Miret et al., 1998; Pelletier et al., 2003). Therefore, understanding the 
mechanisms necessary to resolve hairpin structures is of importance.  
(CTG)n·(CAG)n DM1 model cell lines 
To examine phenotypes of the active (CTG)·(CAG) repeats, we created HeLa 
derived cell lines containing a single ectopic copy of (CTG)·(CAG) repeats 
(representative of normal (12 repeats), pre-mutation (45 repeats), and disease state (102 
repeats)) next to the c-myc replication origin to mimic replication across the 
(CTG)·(CAG) repeats at the endogenous DMPK locus (Liu et al., 2010; Liu et al., 2012). 
The c-myc replicator acts as a point of reference to map the direction of replication. The 
orientation of the (CTG)·(CAG) repeats relative to the c-myc replicator determines which 
repeat (CTG or CAG) becomes the template for leading strand synthesis and the 
complementary repeat is the template for lagging strand synthesis (Liu et al., 2010). This 
model system helped demonstrate that hairpins form during replication, suggesting that 
hairpins can form on either the template DNA or nascent DNA during replication and 
unresolved hairpins present in the template DNA can lead to contractions while hairpins  
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Figure 1: Possible non-B form structures formed at microsatellites during 
replication. (A-D) Schematics of unusual DNA structures formed by repeated 
sequences. (CTG)·(CAG) repeats fold into hairpin structures (A) in vivo, DNA fitting 
the G4 consensus sequence folds into G-quadruplex structures (B), slip strand 
structures can occur at trinucleotide repeats (D), and polypurine·polypyrimidine 
sequences can fold back onto itself creating a triplex (C) when DNA is in a single 
strand conformation. (Adapted from Cooper et al., 2011) 
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Figure 2. Mechanisms for double strand break formation at repetitive DNA 
sequences. (A) Hairpin structures are substrates for DNA repair endonucleases, 
which create nicks in the DNA at the base of the hairpin. The nicked DNA is then 
converted to a double strand break (DSB). (B) Hairpin structures can form on the 5’ 
end of an Okazaki fragment preventing the activity of the flap endonuclease FEN1 
facilitating a cut on the template strand leading to double strand break (DSB) 
formation. (C) Hairpin structures can form in both the template (black) and daughter 
strand (grey) creating a Holliday junction structure which will be converted to two 
hairpin ended molecules that will be further processed by repair proteins into a 
double strand break (DSB). Although hairpins are represented in this figure, other 
noncanonical DNA structures including triplexes and G-quadruplexes would be 
processed in the same manner. (Adapted from Aguilera and Gomez-Gonzalez, 2008) 
DSB DSB DSB
A B C
Template strand
Nascent strand
Endonuclease
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Figure 3: Hairpin-induced trinucleotide repeat instability. Using HeLa derived 
cell lines containing a single copy of (CTG)·(CAG) repeats, we showed hairpins 
form at the trinucleotide repeats during replication and this hairpin formation 
induces instability. Hairpin formation on the template strand during replication 
causes contractions while hairpin formation on the nascent strand during replication 
produces expansions. (Adapted from Liu et al., 2010) 
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Replication
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present in the nascent DNA result in expansions (Figure 3) (Liu et al., 2010). Both 
contractions and expansions represent potentially harmful forms of genome instability 
(Liu et al., 2012). The mechanism necessary for resolving hairpins and maintaining 
genome stability at the (CTG)·(CAG) repeats of the DMPK locus remains unknown. 
Since the frequency of hairpin formation is much higher than the frequency of 
expansion or contraction, the cell likely possesses mechanisms to resolve hairpin 
structures and avoid replication fork stalling. Possible enzymes for hairpin resolution are 
DNA helicases known to unwind noncanonical DNA structures. Genome instability 
disorders arise from mutations or loss of these helicases including the cancer 
predisposition diseases Fanconi anemia (FANCJ  helicase)  (Litman et al., 2005), 
Bloom’s syndrome (BLM helicase) (Ellis et al., 1995), Werner’s syndrome (WRN 
helicase)  (Yu et al., 1996), and Rothmund-Thomson  syndrome (RecQL4 helicase)  
(Kitao et al., 1999).  
Fanconi anemia (FA) and genome instability 
 Many different genome instability diseases exist. FA refers to an autosomal 
recessive disorder characterized by bone marrow failure, developmental abnormalities, 
and cancer predisposition  (Deakyne and Mazin, 2011; Kee and D'Andrea, 2010; 
Niedernhofer et al., 2005). All FA patients possess severe chromosomal instability 
(Deakyne and Mazin, 2011; Niedernhofer et al., 2005). Mutations in one of nineteen 
different FA complementation groups, each complementation group represents mutations 
in a single FANC protein expressing gene, leads to hypersensitivity to interstrand 
crosslinking agents. Initial work categorized a group of eight of genetic complementation  
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Figure 4: Fanconi anemia repair pathway. A schematic of the assembly of FANC 
proteins to the site of an inter-strand crosslink for DNA damage repair. 
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groups  corresponding to a cluster of FANC proteins (FANCA, FANCB, FANCC, 
FANCE, FANCF, FANCG, FANCL, FANCM) that aggregate together in response to 
damaged DNA (Deakyne and Mazin, 2011; Raschle et al., 2008; Xue et al., 2008). 
Recently, an additional core complex protein was identified, the ubiquitin E2 conjugase 
UBE2T (FANCT) (Rickman et al., 2015; Virts et al., 2015). After a DNA damaging 
event, DNA damage sensing kinases (ATR and ATM) phosphorylate FANCM resulting 
in the formation of the FA core complex consisting of these nine FANC proteins  
(Raschle et al., 2008; Shigechi et al., 2012). As an E3 ubiquitin ligase, FANCL functions 
to monoubiquitinate both phosphorylated FANCI and phosphorylated FANCD2 leading 
to FANCI/FANCD2 heterodimerization and translocation of both proteins to the site of 
DNA damage creating nuclear foci (Garner and Smogorzewska, 2011; Joo et al., 2011; 
Raschle et al., 2008). Subsequently, additional FA proteins travel to the site of DNA 
damage including FANCD1 (BRCA2) (Wagner et al., 2004), FANCN (PALB2) 
(Tischkowitz and Xia, 2010), activated (phosphorylated) FANCJ (Levitus et al., 2005), 
BRCA1 (FANCS) (Sawyer et al., 2015), FANCP (SLX4) (Stoepker et al., 2011), 
FANCQ (ERCC4) (Bogliolo et al., 2013), FANCR (RAD51) (Bogliolo and Surralles, 
2015; Wang et al., 2015a), and FANCO (RAD51C) (Somyajit et al., 2012). Once 
assembled at the site of damaged DNA, DNA repair is initiated (Figure 4). In addition to 
resolution of interstrand crosslinks, members of the FA repair pathway are required for 
normal DNA replication and the response to replication stress. Therefore, many FA 
proteins operate in other DNA repair pathways including nucleotide excision repair 
(NER), mismatch repair (MMR), and homologous recombination (HR) (Kee and 
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D'Andrea, 2010). Of interest for this work is the function of the FANCJ helicase, which 
acts in a number of these replication dependent repair processes.    
FANCJ and genome instability 
 Fanconi anemia completion group J patients share classification as a result of 
mutations within the FANCJ gene (Wu et al., 2008). FANCJ was first identified as a 
binding partner of the breast cancer type 1 protein (BRCA1) and was referred to as 
BRCA1-interacting protein 1 (Brip1) (Cantor et al., 2001; Greenberg et al., 2006). 
Further examination of the interaction between FANCJ and BRCA1 revealed that FANCJ 
binds to the BRCA1 C-terminal (BRCT) repeat motif found within the C-terminus of 
BRCA1 binding partners (Cantor et al., 2001). As previously stated, a subset of FA 
patients have mutations within the FANCJ gene and it was later determined FANCJ is 
Brip1 (Litman et al., 2005). The FANCJ gene codes for a helicase functioning to unwind 
DNA in a 5’ to 3’ orientation (i.e. FANCJ moves 5’ to 3’ along a DNA strand) (London 
et al., 2008). FANCJ unwinds noncanonical DNA structures such as G-quadruplexes 
(Figure 1b) and DNA repair intermediate structures such as Holliday junctions (London 
et al., 2008; Wu et al., 2008). Functioning with the FA repair pathway, FANCJ plays a 
role in the protection of genome stability in response to interstrand crosslinking reagents 
(Wu et al., 2008; Wu et al., 2009). Recently, the FANCJ analog in C. elegans, dog-1 
(Youds et al., 2008), was shown to be crucial for genome stability (Cheung et al., 2002; 
Kruisselbrink et al., 2008; Wu et al., 2009). The loss of dog-1 lead to the deletion of G4 
DNA, DNA known to fold into G-quadruplex structures, and this deletion began 
immediately 5’ of the start of the G4 DNA and ended at random locations hundreds of 
nucleotides downstream of the G4 DNA (Cheung et al., 2002; Kruisselbrink et al., 2008). 
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Similar results were seen in chicken cells null for FANCJ (Kitao et al., 2011). The human 
homolog of FANCJ interacts with multiple DNA damage responding proteins including 
BRCA1, the repair nuclease Mre11, the replication and repair protein TopBP1, the single 
strand DNA binding protein RPA, the mismatch repair protein MLH1, and the BLM 
helicase. Blocking the interaction of FANCJ with these proteins leads to reduced cell 
survival under replicative stress. Additionally, mutations resulting in loss of FANCJ 
display similar cellular phenotypes when exposed to replication stress. Recent work has 
indicated a role for FANCJ in DNA replication since FANCJ patient cells are 
hypersensitive to DNA polymerase inhibitors and interstrand crosslinking reagents 
(Levitus et al., 2005; Levran et al., 2005; Litman et al., 2005). Taken together; these 
results suggest an essential role for FANCJ in the maintenance of genome stability 
through a known function of unwinding noncanonical DNA structures. However, the 
exact role FANCJ plays in the protection of genome stability in human systems remains 
unknown. Thus, the work described below focuses on understanding the function of 
FANCJ in microsatellite stabilization. 
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MATERIALS AND METHODS 
Cell Culture 
 Cell lines were derived from a HeLa acceptor cell line containing a single FRT 
(FLP recombinase target) site (HeLa/406 acceptor cell line) on chromosome 18 (Liu et 
al., 2003). Acceptor cells were co-transfected with a plasmid expressing FLP 
recombinase and a donor plasmid containing (CTG)·(CAG) repeats downstream of the c-
myc replicator (integration of the donor plasmid at the FRT site in acceptor lines is 
outlined in Figure 5). Donor plasmids are designed such that the direction of replication 
from the c-myc origin through the repeats is known allowing for identification of which 
repeat (CTG or CAG) acts as leading strand replication template and lagging strand 
template for replication. We developed four different cell lines containing varying 
numbers of (CTG)·(CAG) repeats representing normal and disease states. Each repeat 
was placed next to the c-myc replicator in both the forward and reverse orientation. This 
resulted in two separate cell lines for each number of repeats, the repeat (CTG or CAG) is 
the template for leading strand synthesis during replication in one cell line and the 
template for lagging strand synthesis in the second cell line. Cell lines were named based 
on the repeat present in the lagging strand template (Figure 6). (CTG)102/(CAG)102 
(disease state) cells will be used in all the following experiments and (CTG)12/(CAG)12 
(normal/unaffected) cells will serve as controls, this short repeat length should not be 
susceptible to genome instability.  FANCJ null (752) and 752 cells complemented with  
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Figure 5: Chromosomal integration of c-myc-(CTG)·(CAG) constructs. A 
diagram of stable integration of donor plasmids containing the c-myc replicator 
adjacent to varying lengths of (CTG)·(CAG) repeats to create DM1 model cell lines.  
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Figure 6: Schematic of donor c-myc-(CTG)·(CAG) donor plasmids. A cartoon 
representation of (CTG)·(CAG) donor plasmids. (CTG)·(CAG) repeats are 
positioned downstream of c-myc replicator. Cell lines are termed based on the repeat 
(CTG or CAG) present in the lagging strand (as indicated in red).   
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wild type FANCJ (752+FANCJ WT) (Raghunandan et al., 2015), FANCC, FANCQ, and 
FANCI immortalized Fanconi anemia patient cell lines were generously provided by Dr. 
Helmut Hanenberg (Heinrich-Heine-Universität Düsseldorf). RA3087 (FANCA), 
RA3331 (FANCP), RA2645 (FANCD2), RA3100 (FANCL), RA3226 
(FANCD1/BRCA2), and RA2374 (FANCJ
R798X
) immortalized Fanconi anemia patient 
fibroblast cell lines were kindly provided by Dr. Agata Smogorzewska (Rockefeller 
University) (Kim et al., 2013). Apparently healthy primary fibroblasts (GM08402), 
Bloom’s Syndrome primary fibroblasts (GM166860), SV40 transformed fibroblasts 
(GM08505), Werner Syndrome primary fibroblasts (AG03141), and SV40 transformed 
(AG11395) patient fibroblast cell lines were obtained from Coriell Cell Repositories. All 
cell lines were grown in Dulbeco’s modified Eagle’s medium (DMEM) supplemented 
with 10% fetal bovine serum at 37°C and 5% CO2.  
Aphidicolin/Hydroxyurea treatment of fibroblast cell lines 
To promote noncanonical DNA structure formation, DM1 model cell lines were 
treated with reagents known to slow replication progression in conjunction with knock 
down of proteins of interest. Aphidicolin (APH), a DNA polymerase inhibitor, was used 
to slow replication (~30-50%) at a concentration (0.2 μM) which will not initiate an acute 
DNA checkpoint response (Casper et al., 2002; Glover et al., 1984; Wist, 1980). To test 
whether the results obtained from aphidicolin experiments are drug specific, similar 
experiments were performed in the presence of low dose (0.3 mM) hydroxyurea (HU), 
which also slows replication fork movement leading to upregulation of ribonucleotide 
reductase and firing of dormant replication origins without acutely activating the 
checkpoint response (Chen et al., 2015; Petermann et al., 2010). In contrast to 
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aphidicolin, HU is a ribonucleotide reductase inhibitor. Treatment with these replication 
slowing reagents should enhance possible DNA secondary structure formation at 
microsatellite sequences. All experiments were performed with and without replication 
slowing reagents in conjunction with siRNA against proteins of interest or the control 
siRNA. (CTG)n·(CAG)n cells were given 0.2 μM APH or 0.3mM HU for a total of 10 
days. Fibroblast cell lines were treated with 0.5 μM APH or 0.3 mM HU for 10 days. 
Control, untreated counterparts were plated simultaneously. Cells were harvested on the 
tenth day of treatment using TrypLE ™ Express (Life Technologies 12604), a trypsin 
alternative. 
siRNA Treatment 
(CTG)n·(CAG)n cells at a confluency of 60% were reversely transfected with 
siPort NeoFX transfection reagent (Invitrogen 4510M) and 100 nM (final concentration) 
of small interfering RNA (siRNA) pool (an equal molar mixture of 4 different siRNAs 
targeting the same transcript) (Dharmacon Research, Inc.) targeting FANCJ/Brip1 
(siGENOME SMARTpool M-010587), FANCM (siGENOME SMARTpool M-021955), 
FANCD2 (siGENOME SMARTpool M-016376), BLM (siGENOME SMARTpool M-
007287), or WRN (siGENOME SMARTpool M-010378) in a six-well plate every 48 
hours for a total of five transfections in the presence of aphidicolin or hydroxyurea. Cells 
were harvested using TrypLE ™ Express (Life Technologies) 48 hours post the fifth 
transfection. Control experiments were carried out in parallel using AllStars negative 
nontargeting siRNA (Qiagen SI03650318). 
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PCR     
 Small pool PCR (spPCR). After cells were treated with siRNA and replication 
slowing reagents, DNA was isolated from cells using an E.Z.N.A ® Tissue DNA Kit 
from Omega Bio-Tek (D3396). PCR was performed on a small amount (~1-10 genome 
equivalents) of DNA template (50 pg of genomic DNA) per reaction. Four small pool 
PCR (spPCR) reactions were performed on DNA template from each experimental 
condition. All spPCR reactions occurred in the presence of HotStart Taq polymerase 
MasterMix (Qiagen 203443) and amplification conditions were 95°C (15 min); 35 cycles 
of  94°C (1 min), 54°C (45 s), 72°C (1 min); and final extension at 72°C (7 min). PCR 
products were resolved in 8% polyacrylaminde gels. GelRed (Biotium 41002) stained 
gels were imaged using a Fuji LAS-3000 and the software ImageReader. 
Inverse PCR (iPCR). Samples were derived from CTG102 cell DNA treated 
simultaneously with siFANCJ (5 transfections) and aphidicolin (0.2 μM). DNA (2.5 ug) 
was digested with an excess of MseI (New England BioLabs, Inc. R0525) for 1 hour at 
37°C in a 50μL total volume reaction. After a 20 minute heat inactivation at 65°C, 10 μL 
of the restriction digest reaction was used for ligation. Ligation occurred in the presence 
of T4 DNA ligase (New England BioLabs, Inc. M0202) for 1 hour at 16°C. The ligation 
reaction product was cleaned using the MinElute Reaction Cleanup Kit (Qiagen 28204). 
Amplification of ligation products occurred using iPCR primers (iPCR forward primer: 
5’ CATGCTGTCCAGGCAGGTAGATGA 3’ and iPCR reverse primer: 5’ 
CCGGAACGCAGAAGAATCATAATGGG 3’) with HotStart Taq polymerase 
mastermix (conditions: 15 min at 95°C; 35 cycles of 1 min at 94°C, 45s at 58°C, 1 min at  
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Table 1. Small pool PCR primer pairs used in this work. Primer sets used for 
spPCR to examine instability of repeated sequences and internal controls. 
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72°C; 7 min at 72°C). iPCR products were cleaned using the MinElute Reaction Clean-
up (Qiagen 28204) and used for next generation sequencing. 
A list of primers used in this work can be found in Table 1. 
Western Blotting 
 Whole cell lysates from treated or untreated HeLa cells and fibroblast cells were 
prepared with Mammalian Protein Extraction Reagent (M-PER) (Thermo Scientific 
78501) and protease inhibitor cocktail (Sigma P8340). After SDS-PAGE and transfer to a 
polyvinylidene fluoride (PVDF) membrane (ThermoFisher Scientific 88518), membranes 
were probed using a 1:500 dilution of primary antibody (rabbit FANCJ/Brip1 (Abcam 
ab151509), mouse FANCM (Dr. Lei Li, University of Texas MD Anderson Cancer 
Center) (Wang et al., 2013), mouse FANCD2 (Santa Cruz Biotechnology, Inc. SC-
20022), rabbit BLM-7099 (Dr. Jan Karlseder, The Salk Institute for Biological Studies) 
(Orazio et al., 2011), mouse WRN (Abcam ab66606) and  mouse β-actin (Sigma-Aldrich 
A5441)) overnight at 4°C. After incubation with the corresponding horseradish 
peroxidase (HRP) conjugated secondary antibody at a dilution of 1:1000 at room 
temperature for 1 hour, membranes were imaged on a Fuji LAS-3000 using 
ImageReader.  
Aphidicolin Sensitivity 
 Using a reverse transfection approach, CAG102 cells were transfected with FANCJ 
or control siRNA every 48 hours. Continuous aphidicolin (0.2 μM) treatment began 24 
hours post the first transfection (0 hr) for a total of 96 hours. Fibroblast cells were treated 
continuously with aphidicolin (0.5 μM) for 96 hours. Treated cells were harvested using 
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TrypLE ™ Express (Life Technologies) and viable cells were counted every 24 hours 
using trypan blue (Sigma-Aldrich T8154) exclusion. 
Flow Cytometry 
 FANCJ null fibroblast cells were treated with 0.5 μM aphidicolin for a total of 10 
days. Treated cells were collected and fixed in cold 70% ethanol for 10 minutes at room 
temperature. After washing with PBS and 5mM EDTA (3X; 15 minutes per wash), cells 
were incubated with propidium iodide (PI) (Sigma-Aldrich P4170) for 30 minutes. 
Stained cells were analyzed by flow cytometry.      
Next Generation Sequencing 
 The Case Western Reserve University Genomics Care facility performed next 
generation sequencing analysis on iPCR products of DNA from CTG102 cells treated with 
FANCJ siRNA and aphidicolin. 
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RESULTS 
I. FANCJ is essential for microsatellite stabilization 
FANCJ is necessary for CTG102·CAG102 trinucleotide repeat stability 
 Through interaction with multiple proteins known to respond to noncanonical 
DNA structures and replication stress, FANCJ must play a critical role in DNA 
replication. Noncanonical DNA structures known to slow replication forks include 
CTG·CAG hairpins, G-quadruplexes, and asymmetric purine·pyrimidine (Pu·Py) repeat 
tracts able to form DNA triplexes (H-DNA). Previous work has shown that 
(CTG)102·(CAG)102 microsatellites form hairpins in vivo and stall replication forks (Liu et 
al., 2010). Since FANCJ unwinds DNA structures responsible for inhibition of DNA 
replication and (CTG)102·(CAG)102 repeats form hairpin structures in vivo, we wanted to 
examine the effect of loss of FANCJ helicase on (CTG)102·(CAG)102 repeat stability.  
 HeLa-derived cell lines harboring a single ectopic copy of CTG102·CAG102 
trinucleotide repeats (TNRs) directly downstream of the c-myc core replicator were 
created (Figure 7A). During replication, the CTG102 or CAG102 repeat serves as lagging 
strand template in its respective cell line. A pool of siRNAs was used to knockdown 
FANCJ (Figure 7B) in the absence (control) or presence of a low dose of aphidicolin (0.2 
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Figure 7. FANCJ knockdown leads to loss of ectopic (CTG)·(CAG) 
microsatellite signal in (CTG)102·(CAG)102 cells treated with aphidicolin. (A) 
Diagram of the integration site in (CAG)102·(CTG)102 cell lines. (B) Whole cell 
extracts were isolated after treatment of cells with siRNA against FANCJ and 
aphidicolin for a total of five transfections, or parallel untreated cultures, and 
immunoblotted for FANCJ. (C) Small pool PCR results with primers flanking the 
ectopic (CAG)102·(CTG)102 repeats and  primers for a site without microsatellites, an 
internal control for proper function of the PCR machinery. 
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μM APH) that slows DNA polymerases (~30-50%) and reveals chromosome fragile sites 
without activating the DNA checkpoint response in CTG102·CAG102 cells (Casper et al., 
2002; Glover et al., 1984; Wist, 1980). Non-targeting siRNA was used as a control. 
Duplex small pool PCR (spPCR) analysis of genomic DNA was performed with an 
internal control primer set to assess differences between cells in the population and detect 
expansions, contractions, or breaks (instability) of the microsatellite sequences. spPCR 
results from CTG102 and CAG102 cells showed a dramatic decrease in PCR signal at the 
ectopic site (CTG)·(CAG) repeats in CTG102·CAG102 cells after loss of FANCJ in the 
presence of APH (Figure 7C). However, spPCR of sequences 1-3 kb upstream or 
downstream of the (CTG)·(CAG) repeats of the ectopic site did not exhibit instability 
(Figure 8). In addition to CTG102·CAG102 cells, CTG12·CAG12 cells were constructed. 
Twelve repeats are indicative of a normal range of repeats. Similar to the CTG102·CAG102 
cells, CTG12·CAG12 cells were depleted of FANCJ using siRNA (Figure 9B) and treated 
with APH. Surprisingly, we observed in cells treated with both siFANCJ and APH, PCR 
signal of the (CTG)·(CAG) ectopic site repeats was diminished compared to control cells 
(Figure 9C) suggesting FANCJ is essential for (CTG)·(CAG) trinucleotide repeat 
stability even at nonpathological repeat lengths. 
 As a control to link genome instability to the (CTG)·(CAG) trinucleotide repeats 
at the ectopic site, we created an additional HeLa derived cell line in which the 
(CTG)·(CAG) repeats were replaced with a nonrepetitive sequence at the integration site 
(Figure 10A). Depletion of FANCJ in the presence of aphidicolin in these cells did not 
result in microsatellite instability at the ectopic site (Figure 10B) confirming  
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Figure 8. FANCJ knockdown leads does not lead to spPCR signal loss 1-3kb 
upstream and downstream of (CTG)·(CAG)  repeats. (A, B) Small pool PCR 
results with primers ~1kb upstream of the ectopic (CTG)·(CAG)  repeats and 
primers for an internal control. (C, D) Small pool PCR results with primers ~3kb 
downstream of the ectopic (CTG)·(CAG)  repeats and primers for an internal 
control. 
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Figure 9. FANCJ knockdown leads to loss of ectopic (CTG)·(CAG) 
microsatellite signal in (CTG)12·(CAG)12 cells treated with aphidicolin. (A) 
Diagram of the integration site in (CAG)12·(CTG)12 cell lines. (B) Whole cell 
extracts were isolated after treatment of cells with siRNA against FANCJ and 
aphidicolin for a total of five transfections, or parallel untreated cultures, and 
Western blotted for FANCJ. (C) Small pool PCR results with primers flanking the 
ectopic (CAG)12·(CTG)12 repeats and  primers for an internal control site. 
 
26 
 
  
 
Figure 10. FANCJ knockdown does not lead to spPCR signal loss at a 
nonrepetitive sequence of the ectopic site. Small pool PCR results with primers 
flanking the nonrepetitive sequence at the ectopic site and primers for an internal 
control.  
 
27 
 
microsatellite instability is occurring due to the (CTG)·(CAG) repeats present at the 
ectopic site. Therefore, the ectopic site does not indiscriminately induce instability. 
Small pool PCR is an end-point PCR method which can lead to an over estimate 
of a low abundance template compared to a higher abundant template that has plateaued  
amplification early in the PCR. To determine the sensitivity of our assay, we titrated 
CTG102 DNA, containing one ectopic site copy and four internal control site copies, with 
increasing amounts of HeLa DNA (four internal control site copies, no ectopic site 
copies) (Figure 11). A four-fold dilution of the ectopic copy by the internal control copy 
was easily detected (Figure 11). Therefore, we conclude the loss of PCR signal in cells 
treated with FANCJ knockdown and APH treatment represents the loss or separation of 
primer binding sites flanking the (CTG)·(CAG) repeats in a large majority (≥ 75%) of the 
cell population. 
CTG102·CAG102 cells were also treated with hydroxyurea (0.3 mM HU), a 
ribonucleotide reductase inhibitor, to deplete dNTP pools and inhibit DNA replication 
(Chen et al., 2015; Petermann et al., 2010). This low dose of HU slows replication forks 
and activates dormant origins to promote cell survival without initiating a DNA 
checkpoint response (Chen et al., 2015; Petermann et al., 2010). spPCR results revealed a 
loss of PCR signal at the ectopic site CTG102·CAG102 repeats in cells that had been 
treated with FANCJ siRNA and HU (Figure 12). Taken together, these results suggest a 
role for FANCJ in the maintenance of (CTG)·(CAG) trinucleotide repeat stability during 
replicative stress (APH or HU) independent of (CTG)·(CAG) repeat replication polarity. 
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Figure 11. Titration of CTG102 cell DNA with HeLa cell DNA. Small pool PCR 
results of CTG102 cell DNA (1 ectopic site copy and 4 internal control site copies) 
was mixed with varying concentrations of HeLa DNA (4 internal control site copies 
and no ectopic site copies) resulting in template ratios of ectopic site: internal control 
of 1:4, 1:8, 1:16, 1:32. 
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Figure 12. FANCJ knockdown leads to loss of ectopic (CTG)·(CAG) 
microsatellite signal in (CTG)102·(CAG)102 cells treated with hydroxyurea. (A) 
Diagram of the integration site in (CAG)102·(CTG)102 cell lines. (B) Whole cell 
extracts were isolated after treatment of cells with siRNA against FANCJ and 
hydroxyurea for a total of five transfections, or parallel untreated cultures, and 
immunoblotted for FANCJ. (C) Small pool PCR results with primers flanking the 
ectopic (CAG)102·(CTG)102 repeats and  primers for a site without microsatellites 
serving as an internal control. 
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Figure 13: Expandable repeats associated with human disease. A schematic of 
microsatellites responsible for human disease and the corresponding location along 
the gene affected by the expansion of these repeated sequences. 
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FANCJ is necessary for endogenous microsatellite repeat stability 
  Trinucleotide repeats examined in preliminary experiments are only one class of 
microsatellites associated with disease (Collins et al., 2003). About 3% of the human 
genome consists of microsatellites, although not all of these microsatellites cause disease 
(Subramanian et al., 2003). Other types of disease associated microsatellites include tetra-
nucleotide repeats, penta-nucleotide repeats, mirror repeats, and other trinucleotide  
repeated sequences (Figure 13) (Collins et al., 2003; McMurray, 2010; Subramanian et 
al., 2003). Since FANCJ works to protect the stability of (CTG)·(CAG) trinucleotide 
repeats; FANCJ may also have a function in the prevention of instability at other disease 
related microsatellites. To determine if this function of FANCJ is unique to 
(CTG)·(CAG) trinucleotide repeats, we examined multiple endogenous loci of different 
repeat composition. First, we confirmed (CTG)·(CAG) trinucleotide repeat stabilization 
by FANCJ with the analysis of the endogenous (CTG)·(CAG) repeats of the dystrophia 
myotonica protein kinase (DMPK, chr 19q13.32) gene, spinocerebellar ataxia type 1 
(SCA1, chr 6p22.3) gene, transcription factor 4 (TCF4, chr 18q21.2) gene (referred to 
also as CTG18.1), and expanded repeat domain 1 (ERDA1, chr q21.3) loci. As observed 
for the ectopic site (CTG)·(CAG) repeat, the spPCR results from CAG102 cells depleted 
of FANCJ and treated with APH showed PCR signal loss at these endogenous loci 
(Figure 14). Next, we examined the effect of loss of FANCJ during replicative stress 
(APH) on other non-(CTG)·(CAG) disease associated loci including the penta-nucleotide  
ATTCT repeat of the spinocerebellar ataxia type 10 (SCA10, chr22q13.31) locus, and the 
polypurine·polypyrimidine (Pu·Py) repeat track (thought to form triplexes and/or G-
quadruplexes) of the polycystic kidney disease 1 (PKD1, chr 16p13.3, autosomal  
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Figure 14. FANCJ knockdown leads to the loss PCR signal at multiple 
endogenous microsatellites with aphidicolin treatment. Small pool PCR results 
from endogenous DMPK (CTG repeat), SCA10 (ATTCT repeat), PKD1 (Pu·Py 
mirror repeat), α-1B tubulin (G4 DNA, G-quadruplex), ERDA1 (CTG repeat), SCA1 
(CTG repeat), β-globin (G4 DNA), TCF4 (CTG repeat), FANCJ/BRIP1 (polyT 
repeat), c-MYC (G4 DNA), p53 (poly T repeat), and p63 (poly T repeat) in cells 
treated with siFANCJ or siControl and aphidicolin.  
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Figure 14 (continued). FANCJ knockdown leads to the loss PCR signal at 
multiple endogenous microsatellites with aphidicolin treatment. Small pool PCR 
results from endogenous DMPK (CTG repeat), SCA10 (ATTCT repeat), PKD1 
(Pu·Py mirror repeat), α-1B tubulin (G4 DNA, G-quadruplex), ERDA1 (CTG 
repeat), SCA1 (CTG repeat), β-globin (G4 DNA), TCF4 (CTG repeat), 
FANCJ/BRIP1 (polyT repeat), c-MYC (G4 DNA), p53 (poly T repeat), and p63 
(poly T repeat) in cells treated with siFANCJ or siControl and aphidicolin.  
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Figure 15. FANCJ knockdown leads to the loss PCR signal at multiple 
endogenous microsatellites with hydroxyurea treatment. Small pool PCR results 
from endogenous DMPK (CTG repeat), SCA10 (ATTCT repeat), PKD1 (Pu·Py 
mirror repeat), α-1B tubulin (G4 DNA, G-quadruplex), ERDA1 (CTG repeat), SCA1 
(CTG repeat), β-globin (G4 DNA), TCF4 (CTG repeat), FANCJ/BRIP1 (polyT 
repeat), c-MYC (G4 DNA), p53 (poly T repeat), and p63 (poly T repeat) in cells 
treated with siFANCJ or siControl and hydroxyurea. 
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Figure 15 (continued). FANCJ knockdown leads to the loss PCR signal at 
multiple endogenous microsatellites with hydroxyurea treatment. Small pool 
PCR results from endogenous DMPK (CTG repeat), SCA10 (ATTCT repeat), PKD1 
(Pu·Py mirror repeat), α-1B tubulin (G4 DNA, G-quadruplex), ERDA1 (CTG 
repeat), SCA1 (CTG repeat), β-globin (G4 DNA), TCF4 (CTG repeat), 
FANCJ/BRIP1 (polyT repeat), c-MYC (G4 DNA), p53 (poly T repeat), and p63 
(poly T repeat) in cells treated with siFANCJ or siControl and hydroxyurea. 
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dominant polycystic kidney disease). These additional disease associated microsatellite 
sequences examined vary in nucleotide composition, length, and location throughout the 
genome. Treatment of CAG102 cells with FANCJ siRNA and APH lead to spPCR results 
displaying a loss of PCR signal at all endogenous microsatellites analyzed (Figure 14). 
Additionally, we examined repeat sequences which are not associated with a 
microsatellite disorder including a mono-nucleotide poly T repeat in p63 (chr 3q28), 
FANCJ/BRIP1 (17q23.2), and  p53 (chr 17p13.1), as well as G4 DNA (known to form G-
quadruplexes) of β-globin (chr 11p15.4), α-1B tubulin (chr 12q13.12), and c-MYC (chr 
8q24.21). In the absence of FANCJ and presence of APH, a loss of PCR signal was 
observed in CAG102 cells. Similar results were obtained from spPCR results of CAG102 
cells depleted of FANCJ and treated with HU, in which all endogenous microsatellites 
examined showed a loss of PCR signal (Figure 15). Since the loss of PCR signal is not 
specific to (CTG)·(CAG) repeat tracks, we conclude FANCJ is essential for the 
stabilization of microsatellites across the genome during replicative stress irrespective of 
nucleotide composition and length. 
To account for possible off-target effects of siRNA treatment, immortalized 
Fanconi anemia complementation group J patient fibroblasts (FANCJ null) harboring a 
biallelic frameshift mutation (c.308delG, p.F103fs) were treated with aphidicolin (0.5 μM 
APH). spPCR analysis of all the endogenous microsatellites previously tested revealed a 
dramatic loss of PCR signal compared to internal controls (Figure 16). FANCJ null cells 
treated with HU also displayed PCR signal loss (Figure 17) further strengthening our 
finding that replication stress causes microsatellite instability in FANCJ null or depleted 
cells during replication stress.  
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 While performing APH treatment of FANCJ knocked down and null cells, we 
noticed a hypersensitivity to the APH compared to control cells. We counted CAG102 
cells treated with FANCJ or control siRNA in APH as well as FANCJ null, wild-type and 
FANCA null fibroblast cells treated with APH and confirmed a decrease in the relative 
cell number of FANCJ knocked down or null cells (Figure 18).   
 Next we sought to determine if the phenotype of PCR signal loss at endogenous 
microsatellite sequences could be rescued with the expression of FANCJ wild-type 
cDNA. As expected, expression of wild-type FANCJ cDNA (Figure 19) in FANCJ null 
cells treated with APH (Figure 20) or HU (Figure 21) recovered spPCR signal loss at all 
tested endogenous microsatellite sequences. 
 Although the dose of aphidicolin used in these experiments has previously been 
shown to slow replication fork progress without activating the DNA checkpoint response, 
the spPCR signal loss seems too dramatic to remain under the detection of the checkpoint 
response. Therefore, we examined the cell cycle profiles of FANCJ null cells treated with 
0.5 μM APH at different time points using the DNA stain propidium iodide and flow 
cytometry. Starting as early as 2 days of treatment with APH, FANCJ null cells begin to 
arrest in G2/M when compared to untreated control cells (Figure 22). Coupled with the 
robust loss of PCR signaling at microsatellites, we conclude that double strand breaks 
occur at microsatellites eventually causing a DNA checkpoint response and delayed cell 
division.       
Summary                    
 The presented data suggest a novel role for the DNA helicase FANCJ in 
microsatellite stabilization across the genome during replicative stress. To begin we  
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Figure 16. FANCJ null cells show loss of microsatellite signals after treatment 
with aphidicolin. Small pool PCR across endogenous microsatellite sites using 
DNA from FANCJ null cells treated with aphidicolin.  
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Figure 16 (continued). FANCJ null cells show loss of microsatellite signals after 
treatment with aphidicolin. Small pool PCR across endogenous microsatellite sites 
using DNA from FANCJ null cells treated with aphidicolin.  
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Figure 17. FANCJ null cells show loss of microsatellite signals after treatment 
with hydroxyurea. Small pool PCR across endogenous microsatellite sites using 
DNA from FANCJ null cells treated with hydroxyurea.  
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Figure 17 (continued). FANCJ null cells show loss of microsatellite signals after 
treatment with hydroxyurea. Small pool PCR across endogenous microsatellite 
sites using DNA from FANCJ null cells treated with hydroxyurea.  
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Figure 18. FANCJ depleted cells are hypersensitive to aphidicolin. (A) CAG102 
cells treated with control of FANCJ siRNA and aphidicolin for 96 hours and counted 
every 24 hours. (B) FANCJ null, FANCA null, FANCJ
R798X
, and wild-type 
fibroblast cells treated with aphidicolin continuously for 96 hours and counted every 
24 hours. 
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Figure 19. Expression of FANCJ wild-type cDNA in FANCJ null cells. Whole 
cell lysates of FANCJ null, FANCJ null complimented with FANCJ wild-type 
cDNA, and HeLa cells probed for FANCJ protein.  
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Figure 20. Aphidicolin treatment of FANCJ null +FANCJ WT cDNA cells. 
Small pool PCR results for all endogenous microsatellites in FANCJ null cells 
complimented with FANCJ wild-type cDNA treated with aphidicolin. 
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Figure 20 (continued). Aphidicolin treatment of FANCJ null +FANCJ WT 
cDNA cells. Small pool PCR results for all endogenous microsatellites in FANCJ 
null cells complimented with FANCJ wild-type cDNA treated with aphidicolin. 
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Figure 21. Hydroxyurea treatment of FANCJ null +FANCJ WT cDNA cells. 
Small pool PCR results for all endogenous microsatellites in FANCJ null cells 
complimented with FANCJ wild-type cDNA treated with hydroxyurea. 
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Figure 21 (continued). Hydroxyurea treatment of FANCJ null +FANCJ WT 
cDNA cells. Small pool PCR results for all endogenous microsatellites in FANCJ 
null cells complimented with FANCJ wild-type cDNA treated with hydroxyurea. 
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Figure 22. Cell cycle profiles of FANCJ null cells treated with aphidicolin. (A) 
Propidium iodide DNA stained FANCJ null cells analyzed by flow cytometry after 
2, 4, 6, 8, or 10 days of aphidicolin treatment. (B) Composite of cell cycle profiles. 
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showed (CTG)·(CAG) trinucleotide repeat instability at an ectopic site integrated into the 
HeLa genome in the absence of FANCJ and presence of either APH or HU. However, as 
shown by evaluation of multiple endogenous microsatellite sequences in CAG102 cells 
treated with FANCJ siRNA and APH or HU by spPCR, the function of FANCJ in 
microsatellite stabilization has broad effects. These results were confirmed with the 
treatment of FANCJ null cells with APH or HU. Lastly, expression of wild-type FANCJ 
cDNA in FANCJ null cells rescued the effects of APH or HU treatment establishing a 
direct relationship between FANCJ and microsatellite instability during replicative stress.  
II. FANCJ functions independently of the FA repair pathway   
FA repair pathway activity is not necessary for microsatellite stabilization by 
FANCJ 
 The helicase FANCJ plays a role in the replication dependent Fanconi anemia 
(FA) repair pathway (Kee and D'Andrea, 2010). Classical models of the FA repair 
pathway imply a function to resolve interstrand crosslinks (Kee and D'Andrea, 2010). 
However, recent literature suggests a broader role for the FA repair pathway in the 
resolution of other types of DNA damage including double strand breaks (DSBs) (Kee 
and D'Andrea, 2010). The presence of an interstrand crosslink within DNA activates a 
signaling cascade beginning with the phosphorylation of FANCM followed by the 
assembly of a core complex, consisting 9 other FANC proteins (Kee and D'Andrea, 
2010). Once the core complex assembles, the E3 ubiquitin ligase, FANCL, becomes 
active and monoubiquitinates both FANCD2 and FANCI leading to heterodimer 
formation of FANCI and FANCD2 and localization of both proteins at the site of the 
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interstrand crosslink (Garner and Smogorzewska, 2011; Kee and D'Andrea, 2010). 
Subsequently, downstream effectors, including the helicase FANCJ, localize to the 
damaged DNA for repair to occur (Kee and D'Andrea, 2010). The activation of the FA 
repair pathway is depicted in Figure 3. Since the loss of FANCJ coupled with aphidicolin 
treatment causes instability at a variety of microsatellite sequences producing double 
strand breaks, FANCJ may work in conjunction with the entire FA pathway to play a role 
in genome stabilization. To determine if the activation of the FA repair pathway is 
required for FANCJ to maintain microsatellite stability, we first knocked down the 
initiator protein of the pathway, FANCM, with a pool of siRNAs in CTG102·CAG102 cells 
with and without APH (Figure 23). Results for spPCR experiments using primers 
flanking the ectopic site (CTG)·(CAG) repeats revealed no loss of PCR signal in contrast 
to cells treated with siFANCJ and APH. In addition, all of the endogenous microsatellites 
previously examined also showed no loss of PCR signal in the absence of FANCM and 
presence of APH (Figure 24) suggesting FANCJ functions independent of FANCM 
phosphorylation to maintain microsatellite stability. 
To determine the requirement of FA core complex assembly on FANCJ stabilized 
microsatellites, immortalized FANCA, FANCC, and FANCL null patient cells lines were 
obtained. FA core complex cell lines were treated with either APH or HU for 10 days as 
were immortalized wild-type fibroblast cells as a control. FANCA (Figure 25 and 26), 
FANCC (Figure 27 and 28), FANCL (Figure 29 and 30) null APH or HU treated cells 
produced spPCR products in which no loss of PCR signal was observed at any 
endogenous microsatellite analyzed. Likewise, no microsatellite instability was observed 
in wild-type fibroblast cells treated with aphidicolin (Figure 31) or hydroxyurea (Figure  
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Figure 23. FANCM knockdown does not lead to loss of ectopic (CTG)·(CAG) 
microsatellite signal in (CTG)102·(CAG)102 cells treated with aphidicolin. (A) 
Diagram of the integration site in (CAG)102·(CTG)102 cell lines. (B) Whole cell 
extracts were isolated after treatment of cells with siRNA against FANCM and 
aphidicolin for a total of five transfections, or parallel untreated cultures, and 
immunoblotted for FANCM. (C) Small pool PCR results with primers flanking the 
ectopic (CAG)102·(CTG)102 repeats and  primers  for a site without microsatellites 
serving as an internal control. 
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Figure 24. FANCM knockdown does not lead to loss of PCR signal at multiple 
endogenous sites with aphidicolin treatment. Small pool PCR results of CAG102 
cells treated with siFANCM and aphidicolin. No loss of PCR signal was observed at 
multiple endogenous microsatellites. 
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Figure 24 (continued). FANCM knockdown does not lead to loss of PCR signal 
at multiple endogenous sites with aphidicolin treatment. Small pool PCR results 
of CAG102 cells treated with siFANCM and aphidicolin. No loss of PCR signal was 
observed at multiple endogenous microsatellites. 
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Figure 25. Aphidicolin treatment of FANCA nulls cells. Multiple endogenous 
microsatellites were examined via small pool PCR after aphidicolin treatment in 
FANCA null cells. 
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Figure 25 (continued). Aphidicolin treatment of FANCA nulls cells. Multiple 
endogenous microsatellites were examined via small pool PCR after aphidicolin 
treatment in FANCA null cells. 
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Figure 26. Hydroxyurea treatment of FANCA nulls cells. Multiple endogenous 
microsatellites were examined via small pool PCR after hydroxyurea treatment in 
FANCA null cells. 
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Figure 26 (continued). Hydroxyurea treatment of FANCA nulls cells. Multiple 
endogenous microsatellites were examined via small pool PCR after hydroxyurea 
treatment in FANCA null cells. 
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Figure 27. Aphidicolin treatment of FANCC nulls cells. Small pool PCR across 
repeated sequence loci in FANCC null cells treated with aphidicolin. 
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Figure 27 (continued). Aphidicolin treatment of FANCC nulls cells. Small pool 
PCR across repeated sequence loci in FANCC null cells treated with aphidicolin. 
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Figure 28. Hydroxyurea treatment of FANCC nulls cells. Small pool PCR across 
repeated sequence loci in FANCC null cells treated with hydroxyurea. 
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Figure 28 (continued). Hydroxyurea treatment of FANCC nulls cells. Small pool 
PCR across repeated sequence loci in FANCC null cells treated with hydroxyurea. 
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Figure 29. Aphidicolin treatment of FANCL nulls cells. Multiple endogenous 
microsatellites were examined via small pool PCR after aphidicolin treatment in 
FANCL null cells. 
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Figure 29 (continued). Aphidicolin treatment of FANCL nulls cells. Multiple 
endogenous microsatellites were examined via small pool PCR after aphidicolin 
treatment in FANCL null cells. 
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Figure 30. Hydroxyurea treatment of FANCL nulls cells. Multiple endogenous 
microsatellites were examined via small pool PCR after hydroxyurea treatment in 
FANCL null cells. 
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Figure 30 (continued). Hydroxyurea treatment of FANCL nulls cells. Multiple 
endogenous microsatellites were examined via small pool PCR after hydroxyurea 
treatment in FANCL null cells. 
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Figure 31. Aphidicolin treatment of immortalized wild-type fibroblast cells. 
Small pool PCR across repeated sequence in DNA from immortalized wild-type 
fibroblast cells treated with or without aphidicolin. 
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Figure 31 (continued). Aphidicolin treatment of immortalized wild-type 
fibroblast cells. Small pool PCR across repeated sequence in DNA from 
immortalized wild-type fibroblast cells treated with or without aphidicolin. 
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Figure 32. Hydroxyurea treatment of immortalized wild-type fibroblast cells. 
Small pool PCR across repeated sequence in DNA from immortalized wild-type 
fibroblast cells treated with or without hydroxyurea. 
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Figure 32 (continued). Hydroxyurea treatment of wild-type fibroblast cells. 
Small pool PCR across repeated sequence in DNA from wild-type fibroblast cells 
treated with or without hydroxyurea. 
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33). These data support the conclusion that FANCJ stabilizes microsatellite sequences 
regardless of FA core complex assembly.   
The signal for FANCJ recruitment to the site of DNA damage during a FA repair 
pathway response is heterodimer formation of monoubiquitinated FANCD2 and FANCI.   
Knockdown of FANCD2 using a pool of four siRNAs in CTG102·CAG102 cells treated 
with aphidicolin did not lead to a loss of PCR signal at either the (CTG)·(CAG) ectopic 
site repeats (Figure 33) or endogenous microsatellites (Figure 34) suggesting FANCJ 
works independently of the FA repair pathway to stabilize microsatellite sequences. 
These results were confirmed in immortalized FANCD2 null patient cells treated with 
APH (Figure 35) or HU (Figure 36). In addition, immortalized FANCI null cells were 
treated with either APH (Figure 37) or HU (Figure 38). Examination of endogenous 
microsatellite sequences with spPCR showed no loss of PCR signal indicating FANCJ 
maintains microsatellite stability independent of FANCD2 and FANCI hetereodimer 
formation.  
FANCJ is a downstream effector of the FA repair pathway. Other downstream 
effectors of the FA repair pathway participate in other DNA repair pathways including 
homologous recombination. We sought to determine if microsatellite stabilization is a 
function of these proteins as well. FANCP/SLX4 (Figure 39 and 40), FANCQ/ERCC4 
(Figure 41 and 42), and FANCD1/BRCA2 (Figure 43 and 44) immortalized patient 
fibroblasts were subjected to replicative stress (APH or HU). Microsatellite instability 
was not detected in these cells after replication stress implying FANCJ has a unique role 
in microsatellite stabilization. 
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Figure 33. FANCD2 knockdown does not lead to loss of ectopic (CTG)·(CAG) 
microsatellite signal in (CTG)102·(CAG)102 cells treated with aphidicolin. (A) 
Diagram of the integration site in (CAG)102·(CTG)102 cell lines. (B) Whole cell 
extracts were isolated after treatment of cells with siRNA against FANCD2 and 
aphidicolin for a total of five transfections, or parallel untreated cultures, and 
immunoblotted for FANC D2. (C) Small pool PCR results with primers flanking the 
ectopic (CAG)102·(CTG)102 repeats and  primers for a site without microsatellites 
serving as an internal control. 
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Figure 34. FANCD2 knockdown does not lead to loss of PCR signal at multiple 
endogenous sites with aphidicolin treatment. Small pool PCR results of CAG102 
cells treated with siFANCD2 and aphidicolin showing no patterns of instability at 
multiple endogenous microsatellites. 
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Figure 34 (continued). FANCD2 knockdown does not lead to loss of PCR signal 
at multiple endogenous sites with aphidicolin treatment. Small pool PCR results 
of CAG102 cells treated with siFANCD2 and aphidicolin showing no patterns of 
instability at multiple endogenous microsatellites. 
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Figure 35. Aphidicolin treatment of FANCD2 null cells.  Small pool PCR results 
of DNA from FANCD2 null patient fibroblast cells treated with aphidicolin. 
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Figure 35 (continued). Aphidicolin treatment of FANCD2 null cells.  Small pool 
PCR results of DNA from FANCD2 null patient fibroblast cells treated with 
aphidicolin. 
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Figure 36. Hydroxyurea treatment of FANCD2 null cells.  Small pool PCR 
results of DNA from FANCD2 null patient fibroblast cells treated with hydroxyurea. 
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Figure 36 (continued). Hydroxyurea treatment of FANCD2 null cells.  Small 
pool PCR results of DNA from FANCD2 null patient fibroblast cells treated with 
hydroxyurea. 
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Figure 37. Aphidicolin treatment of FANCI null cells.  Small pool PCR across 
repeated sequences in DNA from FANCI null patient fibroblast cells treated with 
aphidicolin. 
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Figure 37 (continued). Aphidicolin treatment of FANCI null cells.  Small pool 
PCR across repeated sequences in DNA from FANCI null patient fibroblast cells 
treated with aphidicolin. 
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Figure 38. Hydroxyurea treatment of FANCI null cells.  Small pool PCR across 
repeated sequences in DNA from FANCI null patient fibroblast cells treated with 
hydroxyurea. 
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Figure 38 (continued). Hydroxyurea treatment of FANCI null cells.  Small pool 
PCR across repeated sequences in DNA from FANCI null patient fibroblast cells 
treated with hydroxyurea. 
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Figure 39. FANCP null cells do not show microsatellite signal loss treated 
with aphidicolin.  Small pool PCR across repeated sequences in DNA from 
FANCP null patient fibroblast cells treated with aphidicolin. 
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Figure 39 (continued). FANCP null cells do not show microsatellite signal loss 
treated with aphidicolin.  Small pool PCR across repeated sequences in DNA from 
FANCP null patient fibroblast cells treated with aphidicolin. 
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Figure 40. FANCP null cells do not show microsatellite signal loss treated with 
hydroxyurea.  Small pool PCR across repeated sequences in DNA from FANCP 
null patient fibroblast cells treated with hydroxyurea. 
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Figure 40 (continued). FANCP null cells do not show microsatellite signal loss 
treated with hydroxyurea.  Small pool PCR across repeated sequences in DNA 
from FANCP null patient fibroblast cells treated with hydroxyurea. 
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Figure 41. FANCQ null cells do not show microsatellite signal loss treated with 
aphidicolin.  Small pool PCR results from FANCQ null patient fibroblast cells 
treated with aphidicolin. 
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Figure 41 (continued). FANCQ null cells do not show microsatellite signal loss 
treated with aphidicolin.  Small pool PCR results from FANCQ null patient 
fibroblast cells treated with aphidicolin. 
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Figure 42. FANCQ null cells do not show microsatellite signal loss treated with 
hydroxyurea.  Small pool PCR results from FANCQ null patient fibroblast cells 
treated with hydroxyurea. 
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Figure 42 (continued). FANCQ null cells do not show microsatellite signal loss 
treated with hydroxyurea.  Small pool PCR results from FANCQ null patient 
fibroblast cells treated with hydroxyurea. 
90 
 
  
 
Figure 43. FANCD1 null cells do not show microsatellite signal loss treated with 
aphidicolin.  Small pool PCR across repeated sequence loci from FANCD1 null 
patient fibroblast cells treated with aphidicolin. 
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Figure 43 (continued). FANCD1 null cells do not show microsatellite signal loss 
treated with aphidicolin.  Small pool PCR across repeated sequence loci from 
FANCD1 null patient fibroblast cells treated with aphidicolin. 
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Figure 44. FANCD1 null cells do not show microsatellite signal loss treated with 
hydroxyurea.  Small pool PCR across repeated sequence loci from FANCD1 null 
patient fibroblast cells treated with hydroxyurea. 
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Figure 44 (continued). FANCD1 null cells do not show microsatellite signal loss 
treated with hydroxyurea.  Small pool PCR across repeated sequence loci from 
FANCD1 null patient fibroblast cells treated with hydroxyurea. 
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Summary                 
Taken together, these results indicate microsatellite stabilization by FANCJ 
occurs independently of the activity of the other FA repair pathway proteins. We 
examined each step of the FA repair pathway (activation, core complex assembly, 
heterodimer formation and recruitment of downstream effectors) individually through the 
treatment of FANC null patient fibroblast cells with replicative stress (APH or HU). 
Results of these experiments confirmed the novel function of FANCJ in microsatellite 
stabilization occurs independently FA repair pathway function.  
III. Loss of FANCJ with APH treatment leads to DSBs and subsequent 
translocations 
Determination of sites along the genome recombined with the ectopic site 
(CTG)·(CAG) in the absence of FANCJ 
The data presented above show a loss of a PCR signal when small pool PCR is 
performed with primers flanking the ectopic site (CTG)·(CAG) repeats in DM1 model 
cells treated with siRNA against FANCJ and aphidicolin or hydroxyurea (Figure 7 and 
12). These data suggest that the PCR primer binding sites have been separated in cells 
depleted of FANCJ under replicative stress. However, sequences both upstream and 
downstream of the (CTG)·(CAG) repeats are still intact (Figure 8). Standard PCR 
primers were designed to obtain a PCR product extending from the known upstream site 
to the known downstream site across the (CTG)·(CAG) repeats (Figure 45A). DNA 
samples from (CAG)102 (DM1 model) cells treated with both siRNA targeting FANCJ  
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Figure 45: PCR of the ectopic site in DM1 model cells. (A) A map of the PCR 
primer set used to amplify from the known upstream sequence to the known 
downstream through the (CTG)·(CAG) repeats (arrowheads). (B) PCR results using 
primers shown in (A). 
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and aphidicolin failed to produce a standard PCR product using these primers (Figure 
45B) further confirming that the upstream and downstream sequences of the ectopic site 
are no longer within close proximity to one another. We believe a double strand break has 
occurred at or near the ectopic site (CTG)·(CAG) repeats (within 100bp flanking the 
repeat since the PCR primers used for spPCR bind 100bp upstream and downstream of 
the trinucleotide repeats produce loss of PCR signal) leading to recombination of the 
(CTG)·(CAG) repeats with unknown sites along the genome. To understand the 
mechanism by which PCR primer binding sites of the ectopic site are separated, we 
utilized a MseI endonuclease cut site (located near the ectopic site (CTG)·(CAG) 
repeats), a map of the ectopic site including MseI cut sites is shown in (Figure 46), 
coupled with intramolecular ligation to create circularized DNA containing known 
ectopic site sequence and unknown genomic DNA (Figure 46). To amplify only DNA 
sequences of interest, PCR amplification was performed using inverse PCR (iPCR) 
primers (Figure 46) targeting ectopic site sequences still present after treatment with both 
siRNA against FANCJ and aphidicolin. PCR products were separated on an agarose gel; 
a representative image is shown in Figure 47B. PCR products appeared as a smear on the 
agarose gel (Figure 47B) indicating multiple sites along the genome recombined with the 
ectopic (CTG)·(CAG) repeats, size variations (leading to multiple bands on the agarose 
gel “smear”) occur based upon the closest MseI recognition sequence at the unknown 
genomic site. If recombination had not occurred, a single band would be present on the 
gel, representative of the distance between both MseI sites flanking the (CTG)·(CAG) 
repeats of the ectopic site (as seen in control DNA digested with MseI and circularized 
(Figure 47B). We used next generation sequencing (NGS) to create  
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Figure 46: Schematic of experimental design for inverse PCR. (A) A map of the 
ectopic site (white bar) recombining with an unknown sequence in the genome 
(black bar). (B) A schematic of the translocation byproduct containing a section of 
known ectopic site sequence and unknown genomic sequence. Also denoted are 
MseI cut sites (known at the ectopic site and approximated in the unknown 
sequence). (C) Circular DNA products after MseI digestion and ligation. (D) 
Amplification of circularized genomic DNA with reverse PCR primers (arrowheads 
in (B)). Inverse PCR products containing known ectopic site sequence and unknown 
genomic sequence, these PCR products were used for next generation sequencing.  
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Figure 47: iPCR of CAG102 cells. (A) A map of the approach to produce inverse 
PCR product. (B) Represent agarose gel of inverse PCR products.  
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Figure 48. Translocation sites identified by next generation sequencing. 
Cytogenetic locations of DNA sequencing reads containing translocation junctions. 
[bars represent log2(read copy number)] 
100 
 
  
 
Table 2. Microsatellite sequences associated with translocation sites. Majority of 
the translocation sites identified by next generation sequencing had a microsatellite 
present in close proximity.   
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Table 3. Cytogenetic sites are associated with cancer and developmental 
disorders. All cytogenetic positions mapped to the translocation sites are associated 
with cancer or developmental disease.     
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a PCR amplicon library and determine which sites along the genome recombined near the 
ectopic (CTG)·(CAG) repeats at the ectopic site in (CAG)102 cells treated with FANCJ 
siRNA and aphidicolin. 
 NGS data confirmed translocations had occurred between the ectopic site and 
unknown genomic sites. Approximately 28,000 of the reads from the sequencer contained 
translocation junctions between the ectopic site and other chromosomes (Figure 48). 
These translocations appear to have occurred nonrandomly. A large majority of 
translocations occurred between the ectopic site located on chromosome 18 and the 
endogenous c-myc locus on chromosome 8q24.21 via nonallelic homologous 
recombination (NAHR). In addition, recombination occurred with the endogenous 
(CTG)20 of the DMPK locus (chromosome 19q13.32) further suggesting the ectopic site 
is a substrate for NAHR. Microsatellite sequences were observed in close proximity to 
the translocation junction of the identified chromosome sites further supporting 
translocations occur via nonrandom recombination (Table 2). Although, translocation 
sites without microhomology to the ectopic site were also observed. Lastly, the 
cytogenetic positions of the translocation sites have previously been associated with a 
wide array of the cancers, developmental disorders, and developmental disorders with 
predisposition to cancer (Table 3).   
Summary 
The data presented focuses on understanding the mechanisms that lead to loss of 
PCR signal in cells depleted of FANCJ under replicative stress. We utilized an iPCR 
approach to amplify MseI digested genomic DNA containing sequences of the ectopic 
site present after treatment with FANCJ siRNA and aphidicolin. Next generation 
103 
 
sequencing identified genomic chromosomal sites fused with the (CTG)·(CAG) ectopic 
site sequences. We conclude that replication stress induces double strand breaks resulting 
in nonrandom chromosome translocations in FANCJ depleted cells.  
IV. FANCJ stabilizes microsatellites independently of BLM/WRN 
function 
In addition to Fanconi anemia, several other genome instability associated 
diseases exist including Bloom’s Syndrome and Werner’s Syndrome. Bloom’s Syndrome 
(BS) is an autosomal recessive disease derived from mutations in the BLM (Bloom) 
helicase (German, 1995). Similarly, Werner’s Syndrome (WS), also an autosomal 
recessive disease, results from mutations within the WRN (Werner) helicase (Holliday et 
al., 1974). BLM helicase functions to unwind noncanonical DNA structures to protect 
against sister chromatid exchanges and subsequent DNA damage (Li et al., 2001; 
Mohaghegh et al., 2001). Recent evidence suggests that BLM works in conjunction with 
the FA repair pathway to resolve replication stress and maintain chromosome stability 
(Deans and West, 2009; Suhasini and Brosh, 2012; Suhasini et al., 2011). Moreover, 
FANCM, the initiator protein of the FA repair pathway contains two separate binding 
domains: one for FA repair pathway activation and a second for the recruitment of the 
BLM complex (Deans and West, 2009). More recently, it was shown that BLM helicase 
and FANCJ directly interact and are functionally linked (Suhasini et al., 2011). BLM 
unwinds DNA in a 3’ to 5’ orientation and FANCJ helicase unwinds DNA in a 5’ to 3’ 
direction (Li et al., 2001; Suhasini et al., 2011). Additionally, a direct relationship 
between protein level of BLM helicase and FANCJ helicase exists, BLM helicase protein 
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levels are decreased in FANCJ helicase depleted cells (Suhasini et al., 2011). Evidence 
exists suggesting that BLM helicase and FANCJ helicase work in concert to maintain 
genome stability by unwinding DNA in opposite orientations (Suhasini et al., 2011). In 
comparison, WRN helicase also unwinds noncanonical DNA structures to protect 
telomeres and prevent pre-mature aging, a hallmark of WS (Li et al., 2001; Mohaghegh et 
al., 2001). Current research implies a role for WRN helicase in the stability of fragile 
sites as evidenced by the accumulation of gaps and breaks in DNA at common fragile 
sites after aphidicolin treatment of WS (WRN null) patient fibroblasts compared to 
control normal fibroblast cells treated with aphidicolin (Pirzio et al., 2008). Additionally, 
in vitro work with human nuclear extracts and (CTG)·(CAG) containing plasmids 
showed WRN is necessary for resolving large CTG/CTG hairpins (Chan et al., 2012). 
Most recently, WRN has been shown to compensate for loss of the Fanconi anemia repair 
pathway in the protection against genome instability after mitomycin C (MMC) treatment 
(Aggarwal et al., 2013). Our data indicates a role for FANCJ in the protection of 
microsatellite stability; thus it is possible that interactions between BLM/WRN and 
FANCJ may also be necessary for the stability of trinucleotide repeats. A model for 
collaboration between FANCJ and BLM/WRN to maintain genome stability is depicted 
in Figure 49. 
FANCJ can function independently of BLM helicase activity 
To understand the role BLM helicase may have in conjunction with FANCJ to 
maintain microsatellite stability, we knocked down BLM helicase using a pool of four 
siRNAs in CTG102·CAG102 cells (Figure 50B) and exposed them to the replicative 
stressor aphidicolin. Cells depleted of BLM and treated with APH did not show  
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Figure 49: FANCJ works in conjunction with WRN or BLM to unwind 
secondary DNA structures. A proposed model for FANCJ to collaborate with 
WRN or BLM helicase to unwind non-B form structures simultaneously on the 
leading template (WRN or BLM) and lagging template (FANCJ) (A) or the same 
noncanonical DNA structure (B) for error-free DNA replication. 
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Figure 50. BLM knockdown does not lead to loss of ectopic (CTG)·(CAG)  
microsatellite signal in (CTG)102·(CAG)102 cells treated with aphidicolin. (A) 
Diagram of the integration site in (CAG)102·(CTG)102 cell lines. (B) Whole cell 
extracts were isolated after treatment of cells with siRNA against BLM and 
aphidicolin for a total of five transfections, or parallel untreated cultures, and 
immunoblotted for BLM. (C) Small pool PCR results with primers flanking the 
ectopic (CAG)102·(CTG)102 repeats and  primers for a site without microsatellites 
serving as an internal control. 
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Figure 51. BLM knockdown does not lead to loss of PCR signal at multiple 
endogenous sites with aphidicolin treatment. Small pool PCR results of CAG102 
cells treated with siBLM and aphidicolin showing no patterns of instability at 
multiple endogenous microsatellites. 
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Figure 51 (continued). BLM knockdown does not lead to loss of PCR signal at 
multiple endogenous sites with aphidicolin treatment. Small pool PCR results of 
CAG102 cells treated with siBLM and aphidicolin showing no patterns of instability 
at multiple endogenous microsatellites. 
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Figure 52. BLM null cells exposed to aphidicolin. Small pool PCR results for 
DNA from BLM null patient cells treated with aphidicolin. 
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Figure 52 (continued). BLM null cells exposed to aphidicolin. Small pool PCR 
results for DNA from BLM null patient cells treated with aphidicolin. 
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Figure 53. BLM null cells exposed to hydroxyurea. Small pool PCR results for 
DNA from BLM null patient cells treated with hydroxyurea. 
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Figure 53 (continued). BLM null cells exposed to hydroxyurea. Small pool PCR 
results for DNA from BLM null patient cells treated with hydroxyurea. 
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Figure 54. WRN knockdown does not lead to loss of ectopic (CTG)·(CAG)  
microsatellite signal in (CTG)102·(CAG)102 cells treated with aphidicolin. (A) 
Diagram of the integration site in (CAG)102·(CTG)102 cell lines. (B) Whole cell 
extracts were isolated after treatment of cells with siRNA against WRN helicase and 
aphidicolin for a total of five transfections, or parallel untreated cultures, and 
immunoblotted for BLM. (C) Small pool PCR results with primers flanking the 
ectopic (CAG)102·(CTG)102 repeats and  primers for a site without microsatellites. 
serving as an internal control. 
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microsatellite instability (loss of spPCR signal) at the ectopic site (CTG)·(CAG) repeats 
(Figure 50C) and endogenous microsatellites (Figure 51). spPCR results were confirmed 
in primary Bloom’s Syndrome patient fibroblast cells (BLM null) treated with 
aphidicolin (Figure 52) or hydroxyurea (Figure 53) suggesting BLM helicase activity is 
dispensable for FANCJ to stabilize microsatellite sequences. 
FANCJ can function independently of WRN helicase activity 
Similarly, we examined the requirement of WRN activity for microsatellite 
stabilization by FANCJ. CTG102·CAG102 cells were depleted of WRN helicase with a 
pool of siRNAs (Figure 54B) and treated with aphidicolin. DNA isolated from cells 
treated with both WRN siRNA and aphidicolin showed a similar pattern of spPCR 
products compared to control counterparts at the ectopic site (CTG)·(CAG) repeats 
(Figure 54C) and endogenous microsatellites (Figure 55), in contrast to spPCR products 
produced from CTG102·CAG102 cells treated with FANCJ siRNA and aphidicolin (Figure 
7). Lack of spPCR signal loss at endogenous microsatellite sequences was confirmed in 
primary Werner’s Syndrome patient cells exposed to aphidicolin (Figure 56) and 
hydroxyurea (Figure 57) to induce replication stress signifying WRN helicase function is 
expendable for FANCJ to maintain microsatellite stability. 
A normal primary fibroblast cell line was treated with aphidicolin (Figure 58) or 
hydroxyurea (Figure 59) as a control for primary BLM helicase null and primary WRN 
helicase null cell lines exposed to replicative stress. Under both conditions, no loss of 
PCR signal at endogenous microsatellite sequences was observed.    
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Figure 55. WRN knockdown does not lead to loss of PCR signal at multiple 
endogenous sites with aphidicolin treatment. Small pool PCR results of CAG102 
cells treated with siWRN and aphidicolin showing no patterns of instability at 
multiple endogenous microsatellites. 
116 
 
  
 
Figure 55 (continued). WRN knockdown does not lead to loss of PCR signal at 
multiple endogenous sites with aphidicolin treatment. Small pool PCR results of 
CAG102 cells treated with siWRN and aphidicolin showing no patterns of instability 
at multiple endogenous microsatellites. 
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Figure 56. Aphidicolin treatment of WRN null patient cells. Small pool PCR 
across repeated sequences in DNA from WRN null patient cells treated with 
aphidicolin. 
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Figure 56 (continued). Aphidicolin treatment of WRN null patient cells. Small 
pool PCR across repeated sequences in DNA from WRN null patient cells treated 
with aphidicolin. 
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Figure 57. Hydroxyurea treatment of WRN null patient cells. Small pool PCR 
across repeated sequences in DNA from WRN null patient cells treated with 
hydroxyurea. 
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Figure 57 (continued). Hydroxyurea treatment of WRN null patient cells. Small 
pool PCR across repeated sequences in DNA from WRN null patient cells treated 
with hydroxyurea. 
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Figure 58. Primary normal fibroblast cells treated with aphidicolin. Small pool 
PCR across repeated sequences in DNA from primary normal fibroblasts treated 
with aphidicolin. 
 Primary wild-type cells 
122 
 
  
 
Figure 58 (continued). Primary normal fibroblast cells treated with aphidicolin. 
Small pool PCR across repeated sequences in DNA from primary normal fibroblasts 
treated with aphidicolin. 
 
 Primary wild-type cells 
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Figure 59. Primary normal fibroblast cells treated with hydroxyurea. Small 
pool PCR across repeated sequences in DNA from primary normal fibroblasts 
treated with hydroxyurea. 
 Primary wild-type cells 
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Figure 59 (continued). Primary normal fibroblast cells treated with 
hydroxyurea. Small pool PCR across repeated sequences in DNA from primary 
normal fibroblasts treated with hydroxyurea. 
 
 Primary wild-type cells 
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Summary 
The present data focus on understanding the potential roles for BLM helicase or 
WRN helicase in FANCJ microsatellite stabilization. Recent studies have indicated a 
cooperative effort between FANCJ and BLM/WRN helicase to maintain genome 
integrity. First, we examined the effect of loss of BLM helicase on microsatellite 
stability. Replicative stress does not lead to loss of spPCR signal at the ectopic site 
(CTG)·(CAG) repeats and endogenous microsatellites in BLM helicase depleted cells 
suggesting BLM helicase activity is nonessential for FANCJ to stabilize microsatellites. 
Similarly, induction of replicative stress in WRN depleted and null cells did result in loss 
of spPCR signal indicating WRN helicase is dispensable for FANCJ mediated 
microsatellite stabilization. Taken together, these results suggest FANCJ can function in 
the absence of BLM helicase or WRN helicase to maintain microsatellite stability. 
V. FANCJ mutagenesis 
FANCJ stabilizes microsatellites independent of BRCA1, TopBP1 and BLM 
interaction 
Work presented above demonstrates a role for FANCJ in the maintenance of 
genome stability (Figure 7). However, the domain(s) necessary for this function of 
FANCJ remain(s) unknown. Towards characterizing this role we obtained an 
immortalized Faconi anemia complementation group J patient cell line expressing a 
biallelic mutant of FANCJ (FANCJ
R798X
). This mutation results in an arginine switch to a 
premature stop codon. The protein product of the mutagenized gene eliminates the   
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Figure 60: Schematic of FANCJ protein. FANCJ consists of a helicase (comprised 
of 7 helicase domains, BRCA1 binding domain, TopBP1 binding domain, RPA 
binding domain, BLM binding domain, MLH1 binding domain, iron-sulfur cluster 
(Fe-S) and nuclear localization signal. (Wu and Brosh, 2009)  
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Figure 61. FANCJ
R798X
 mutant cells are insensitive to microsatellite loss with 
aphidicolin treatment. Small pool PCR across endogenous repeated sequences in 
DAN from biallelic FANCJ
R798X
 patient fibroblasts with aphidicolin.   
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Figure 61 (continued). FANCJ
R798X
 mutant cells are insensitive to microsatellite 
loss with aphidicolin treatment. Small pool PCR across endogenous repeated 
sequences in DAN from biallelic FANCJ
R798X
 patient fibroblasts with aphidicolin.   
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Figure 62. FANCJ
R798X
 mutant cells are insensitive to microsatellite loss with 
hydroxyurea treatment. Small pool PCR across endogenous repeated sequences in 
DAN from biallelic FANCJ
R798X
 patient fibroblasts with hydroxyurea.   
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Figure 62 (continued). FANCJ
R798X
 mutant cells are insensitive to microsatellite 
loss with hydroxyurea treatment. Small pool PCR across endogenous repeated 
sequences in DAN from biallelic FANCJ
R798X
 patient fibroblasts with hydroxyurea.   
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following previously identified functional domains: BRCA1 binding domain, TopBP1 
binding domain, and BLM helicase binding domain (Figure 60). Recent research suggests 
each domain is necessary to allow FANCJ to function properly to unwind noncanonical 
DNA structures and promote genome stability in the presence of interstrand crosslinking 
agents (Cantor et al., 2001; Gong et al., 2010; Greenberg et al., 2006; Leung et al., 2011; 
Suhasini and Brosh, 2012; Suhasini et al., 2011). Therefore, it is feasible that these 
domains are essential for FANCJ to function as a protector of microsatellite stability. In 
addition, in vitro analysis of FANCJ
R798X
 recombinant protein isolated from Sf9 insect 
cells shows a loss of helicase activity with this mutation (London et al., 2008). To 
determine if these domains of FANCJ are essential for microsatellite stabilization, we 
treated FANCJ
R798X
 cells with either aphidicolin (Figure 61) or hydroxyurea (Figure 62) 
to induce replication stress and examined microsatellite stability via spPCR. PCR 
products revealed no loss of signal at endogenous microsatellite sequences, in contrast to 
FANCJ null cells exposed to replicative stress. If these domains were necessary for 
FANCJ to maintain microsatellite stability, similar patterns of instability would be 
observed in the FANCJ
R798X
 (Figure 61 and 62) and FANCJ (Figure 16 and 17) null cells. 
Since no instability was observed in FANCJ
R798X
 cells treated with aphidicolin or 
hydroxyurea, we conclude that the BRCA1, TopBP1, and BLM helicase binding domains 
are not required for FANCJ to stabilize microsatellites across the genome during 
replicative stress.  
Summary 
The experiments performed above aim to determine which domains of FANCJ are 
required for FANCJ to stabilize microsatellite sequences under replicative stress 
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conditions. Immortalized Fanconi anemia patient cells harboring a truncation mutation of 
FANCJ (FANCJ
R798X
) abolishing BRCA1, TopBP1, and BLM helicase interacting 
domains were exposed to replicative stress. spPCR results showed no patterns of 
microsatellite instability indicating these domains are nonessential for FANCJ to stabilize 
microsatellite sequences.  
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DISCUSSION 
 The data presented here suggest a novel role for FANCJ helicase in the protection 
of microsatellite stability. Although FANCJ is known to unwind DNA G-quadruplex and 
triplex structures, it was not clear whether this activity extended to other noncanoncial 
DNA structures or was important in vivo. Here, we show in vivo in human cells that 
FANCJ helicase is essential to stabilize microsatellites prone to adopt noncanoncial DNA 
structures during replication stress. This unique function of FANCJ occurs independently 
of the FA repair pathway, irrespective of BLM helicase and WRN helicase activity, and 
without the interaction sites for BRCA1 or TopBP1.     
FANCJ helicase in (CTG)·(CAG) repeat stability 
Expansions of the (CTG)·(CAG) repeats in the 3’ untranslated region of the 
DMPK gene cause several of the phenotypes associated with DM1 on a cellular level. In 
cell models, expansion or contraction of the (CTG)·(CAG) trinucleotide repeats can be 
induced with cycles of replication stress followed by recovery (Liu et al., 2012). The data 
presented here shows (CTG)·(CAG) repeats are sites of chromosome fragility with the 
depletion of FANCJ helicase in the presence of continuous replication stress, as might be 
experienced in vivo. Hence, the knockdown of FANCJ helicase in (CTG)102·(CAG)102 
DM1 model cells treated with replicative stressors produced instability of the ectopic site 
(CTG)·(CAG) repeats. These results open the possibility that replication restart during 
repeated cycles of replicative stress and recovery induces a different pattern of instability 
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than continuous replication stress. Additionally, we show a new mechanism for 
microsatellite instability, double strand break formation. Classically, instability of 
microsatellite sequences was determined by the expansion or contraction in the number 
of (CTG)·(CAG) repeats (Fernandez-Lopez et al., 2004; McMurray, 2010; Zeman and 
Cimprich, 2014).   
In addition to (CTG)102·(CAG)102 repeats, we also examined the effect of loss of 
FANCJ on (CTG)12·(CAG)12 repeats with the treatment of aphidicolin. Surprisingly, this 
normal repeat length was also unstable under these conditions. These results suggest 
FANCJ is necessary for the stability of all microsatellite sequences pathological and 
nonpathological increasing the importance in understanding the mechanism behind this 
phenomenon.   
We observed a difference in sensitivity to FANCJ helicase depletion and 
aphidicolin treatment between (CTG)n and (CAG)n cells. Irrespective of (CTG)·(CAG) 
repeat length, (CAG)n cells were more sensitive to aphidicolin and FANCJ helicase 
depletion compared to (CTG)n cells. This observation has also been seen by other 
researchers in the laboratory. We believe this different in sensitivity leads to the 
variability in small pool PCR signal loss at the ectopic site (CTG)n·(CAG)n repeats 
between (CAG)n cells and (CTG)n cells.  
FANCJ is essential for microsatellite stability across the genome       
 Trinucleotide repeats consisting of (CTG)·(CAG) sequences represent only one 
subset of microsatellite sequences. Other subtypes of microsatellites varying in length 
and nucleotide composition exist. Collectively, microsatellites make up approximately 
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3% of the entire genome. Surprisingly, multiple endogenous microsatellites showed 
instability with the depletion of FANCJ helicase and presence of aphidicolin or 
hydroxyurea in CAG102 cells. The same endogenous microsatellites were also unstable in 
FANCJ null fibroblast cells exposed to replication stress indicating microsatellite 
instability is not limited to (CTG)·(CAG) trinucleotide repeats but transpires at diverse 
microsatellite sequences. FANCJ null cells complemented with FANCJ wild-type cDNA 
rescued the phenotype of microsatellite instability under replication stress in FANCJ null 
cells solidifying a role for FANCJ helicase in microsatellite stabilization across the 
genome during replication stress. Previous work has shown that FANCJ null cells exhibit 
an increased level of chromosomal abnormalities when exposed to naturally occurring 
replication stress (Kuzminov, 2013; Noda et al., 2011), therefore, our work suggests 
diverse microsatellites are inherently prone to breakage and FANCJ is required for the 
prevention of double strand break formation during natural replication stress. Further, 
these results raise the question of whether there is a common intermediate, such as a 
stalled replication fork, which leads to double strand breaks. Additionally, our results 
suggest that microsatellite instability can be used as diagnostic tool to assay for FANCJ 
deficiency. 
 We noticed differences in the extent of small pool PCR signal loss between 
microsatellite sequences across the genome. The stability of secondary (non-B form) 
DNA structures varies (Bochman et al., 2012). We suspect the difference in stability 
between hairpins, triplexes, G-quadruplexes and other non-B form structures leads to 
differential small pool PCR signal loss.  
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 Recently, a FANCJ helicase null mouse was created. Mouse embryonic 
fibroblasts (MEFs) from the knockout mouse model for FANCJ helicase show increased 
sensitivity to aphidicolin when compared to FANCJ proficient controls (Matsuzaki et al., 
2015). Additionally, genomic instability is observed at a number of microsatellite 
sequences across the genome, homologous murine microsatellites sites to microsatellites 
sites we conveyed (Matsuzaki et al., 2015), confirming our results suggesting FANCJ is 
necessary for microsatellite stabilization during replication stress. 
DSBs induced by depletion of FANCJ and replicative stress lead to G2/M 
arrest 
 Experiments presented in this work were conducted in the presence of a low dose 
of aphidicolin or hydroxyurea that does not acutely activate the DNA checkpoint 
response (Casper et al., 2002; Chen et al., 2015; Glover et al., 1984; Petermann et al., 
2010; Wist, 1980). However, we examined the cell cycle profiles of FANCJ null cells 
and HeLa cells treated with siControl or siFANCJ exposed to aphidicolin and determined 
that the cells depleted of FANCJ are more sensitive to aphidicolin treatment. 
Additionally, FANCJ null cells treated with aphidicolin accumulated in the G2/M phase 
of the cell cycle indicative of a DNA checkpoint response. Previously published data of 
cell cycle profiles from normal fibroblast cells treated with aphidicolin show a slower 
progression through S phase indicative of aphidicolin affecting replication polymerases 
(Mao et al., 2008b). Here we show the additive loss of FANCJ helicase, in FANCJ null 
cells, leads to a different cell cycle profile, in which cells stall in the G2/M phase. 
Experiments are under way in the laboratory to assess the phosphorylation status of the 
DNA checkpoint kinase 1 (Chk1) and checkpoint kinase 2 (Chk2) as well as the kinases 
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upstream of Chk1 and Chk2, Ataxia telangiectasia mutated (ATM) and Ataxia 
telangiectasia and Rad3 related kinase (ATR) to understand the mechanism of checkpoint 
activation in cells depleted of FANCJ under replication stress.  
FANCJ functions independently of the FA repair pathway  
 FANCJ is the helicase associated with the FA repair pathway. Activation of the 
FA repair pathway occurs in response to replication stress and DNA damage. The 
requirement of FA repair pathway activation for FANCJ to stabilize microsatellites was 
examined. Knockdown of FANCM and FANCD2 in (CTG)102·(CAG)102 DM1 model 
cells exposed to replicative stress does not lead to instability of ectopic site 
(CTG)·(CAG) repeats or endogenous microsatellites suggesting FANCJ functions 
independently of the FA repair pathway to maintain microsatellite stability. FANC null 
patient cells treated with either aphidicolin or hydroxyurea to induce replication stress 
show a similar pattern of instability at all endogenous microsatellites analyzed 
confirming FANCJ helicase stabilizes microsatellites irrespective of activation of the FA 
repair pathway. A concern of the experimental approach may be that instability is 
occurring and goes undetected by our end-point PCR approach. Endogenous sites and the 
ectopic site were examined in multiple FANC null protein conditions both with and 
without replicative stress. Small pool PCR results under all combination of conditions 
(different FANC protein null cells treated with aphidicolin or hydroxyurea) did not show 
variability in results, no loss in spPCR signal. If instability was taking place, it is likely 
that we would have observed inconsistencies in small pool PCR results. In addition, we 
performed a small pool PCR titration experiment in which we varied the ratio of copy 
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number between the ectopic site and an internal control site. It was evident that loss of 
PCR signal is detectable via our end-point small pool PCR method.    
 Recently, a number of FANC proteins have been implicated in DNA replication 
and repair processes independent of the FA repair pathway, as we have shown for 
FANCJ. To begin, FANCM functions with associated protein FAAP24 to recognize 
DNA damage and mediate the Ataxia telangiectasia and Rad3 related kinase (ATR)/ 
checkpoint kinase 1 (Chk1) checkpoint response to prevent accumulation of unrepaired 
DNA damage independent of the FA core complex (Collis et al., 2008; Schwab et al., 
2010; Wang et al., 2013). In addition, ATR-mediated replication fork restart is deficient 
in FANCM null cells when compared to other FANC null cells (FANCC and FANCI) 
(Schwab et al., 2010). Phosphorylation of FANCI by ATR in response to replication 
stress leads to dormant origin firing and replication fork restart (Chen et al., 2015). 
FANCD2 functions with BLM helicase to promote replication fork recovery 
independently of FANCI and the FA pathway (Chaudhury et al., 2013). Most recently, 
FANCD2, FANCD1/BRCA2, and FANCJ have been implicated in replication fork 
recovery after treatment with aphidicolin or hydroxyurea independently of the FA core 
complex (Raghunandan et al., 2015). Taken together, it is not surprising FANCJ 
functions irrespective of FA repair pathway activation. FANCM, FANCI, FANCD2, and 
FANCD1/BRCA2 depleted or null cells were treated with aphidicolin and hydroxyurea. 
Microsatellite instability was not detected under these conditions suggesting the FA 
independent roles of other FANC proteins are also not essential for FANCJ to stabilize 
microsatellites further confirming a uniquely novel function for FANCJ helicase in the 
protection of microsatellite integrity. 
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 Coupled with recent work from MEFs from FANCJ helicase null mice 
(Matsuzaki et al., 2015), our results suggest FANCJ helicase functions independently of 
the FA repair pathway to stabilize microsatellite sequences. We suspect FANCJ functions 
in different DNA repair processes based upon interaction with different repair proteins. 
For function in the FA repair pathway FANCJ requires helicase activity and interaction 
with BRCA1 (phosphorylation at serine 990). However, for stabilization of 
microsatellites, FANCJ does not rely on activation of the FA repair pathway.   
Translocations occur in FANCJ depleted cells during replicative stress 
    (CTG)102·(CAG)102 DM1 model cells depleted of FANCJ helicase and treated 
with aphidicolin resulted in (CTG)·(CAG) trinucleotide repeat stability. Interestingly, 
sequences 1-3kb from the (CTG)·(CAG) repeats of the ectopic site remained intact while 
primers <100 bp from the repeats did not give a PCR product. These data suggested the 
primer binding sites used for spPCR are no longer in close proximity to one another, 
which would result from a double strand break (DSB). To determine if double strand 
breaks lead to translocations and where those translocations are located, we employed an 
inverse PCR (iPCR) approach. Long distance iPCR has previously been used to identify 
translocations in cancer cells and many reports have discussed importance of iPCR 
approaches to determine unknown translocation sites (Benkel and Fong, 1996; Ochman et 
al., 1988; Schneider et al., 2011) supporting iPCR as a good technique to determine 
translocations at the ectopic site. Coupling iPCR with next generation sequencing (Meier 
and Gartner, 2014) proved to be the ideal application. Inverse PCR results revealed that 
translocations occurred between the ectopic site (CTG)·(CAG) repeats and another 
genomic site. Translocation sites determined by iPCR have been identified 
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cytogenetically. The cytogenetic positions of all the translocation sites we have identified 
have previously been associated with chromosome instability, cancer, and developmental 
disorders. Chromosome 2p22.3 is linked to small cell lung carcinoma (Lui et al., 2001), 
sesorineural nonsyndromic recessive deafness (Chaib et al., 1996), and Maffucci 
syndrome (development of multiple enchondromas associated with hemangiomas, 
predisposed to CNS, pancreatic, and ovarian malignancies) (Amyere et al., 2014). In 
addition, chr. 2q12.2 is associated with small cell lung carcinoma (Lui et al., 2001) and 
chr. 2q34 with breast cancer (Kim et al., 2012) and Bjornstad syndrome (developmental 
disorder associated with deafness) (Lubianca Neto et al., 1998). Ovarian cancer 
(Kamieniak et al., 2015; Wan et al., 1999), breast cancer (Li et al., 2007), neuroblastoma 
(Li et al., 2007), and melanoma (Li et al., 2007) have been linked to chr. 6q24.1. 
Chromosome 7p15.3 is connected with multiple disorders including Dandy Walker 
syndrome (brain malformations) (Chen et al., 2010), hand-foot-genital syndrome (limb 
malformations and urogenital abnormalities) (Hosoki et al., 2012), myeloma (Broderick 
et al., 2012; Martino et al., 2012; Weinhold et al., 2015), childhood lymphoma/leukemia 
(Kaneko et al., 1988) and ovarian cancer (Li et al., 2014; Shimada et al., 2013). 
Chromosome 8q24.21 associates with gliomas (Enciso-Mora et al., 2013; Lu et al., 2015), 
renal cell carcinoma (Gudmundsson et al., 2013), male breast cancer (Silvestri et al., 
2015), lymphoma (Enciso-Mora et al., 2010), and T-cell leukemia (Crowther-Swanepoel 
et al., 2010). Chromosome 10q22.3 is linked to Cowden disease (growth of multiple 
hamartomas and increased risk of cancer) (Nelen et al., 1996), breast cancer (Chen et al., 
2012; Kiyotani et al., 2012), ovarian cancer (Ho et al., 2009), non-small cell lung cancer 
(Petersen et al., 1998; Yendamuri et al., 2008), and prostate cancer (Lu and Hano, 2008; 
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Pan et al., 2001). Chromosome 11p15.4-5 relates to breast cancer (Wikman et al., 2012), 
Silver-Russell syndrome (delayed growth rate before and after birth) (Demars and 
Gicquel, 2012; Eggermann et al., 2010), Beckwith Wiedemann syndrome (entire body 
developmental abnormalities coupled with cancer predisposition) (Baskin et al., 2014; 
Demars and Gicquel, 2012; Demars et al., 2011), and T lymphoid leukemia (Crescenzi et 
al., 2015). Hepatocellular carcinoma (Wang et al., 2015b) and colorectal cancer 
(Houlston et al., 2010) have been linked to chr. 20q13.13. We also note with interest that 
a majority of the 300-500bp  translocation site reads had a sequence predicted to form 
noncanonical DNA structures, and are prone to double strand breaks in the absence of 
FANCJ during replication stress from our studies, near the translocation junction (2p22.3 
– G300; 2q12.2 – G4; 2q34 – G4; 7p15.3 – G4; 8q24.21 – G4; 11p15.4 – G4; 20q13.13 – 
G4; 6q24.1 – T20; 19p13.32 – CTG20). We predict that DSBs form at microsatellite 
sequences resulting in pools of free DNA ends which are substrates for classical DNA 
repair pathways including non-homologous ending joining and microhomology-mediated 
end joining, or form structures which cannot be resolved by classical DNA repair 
processes. The high frequency of microsatellite DSBs in FANCJ depleted and null cells 
during replication stress prompts us to consider that inherited or stochastic FANCJ 
deficiency may pose a threat to proper replication of sequences known to form 
noncanonical DNA structures resulting in chromosome aberrations. As a protector of 
microsatellites, FANCJ possibly participates in the prevention of cancer and 
developmental disorders broadening current understanding of FANCJ function. 
 Our data show double strand break formation at microsatellite sequences in cells 
depleted of FANCJ helicase under replicative stress. The approach used in our 
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experiments analyzes the repair of structure induced DNA breaks (double strand breaks 
resulting from the presence of noncanonical DNA structures). The most common method 
for identifying repair proteins and processes involved in the repair of double strand 
breaks occurs through utilization of an I-Sce1 endonuclease restriction site (Choulika et 
al., 1995; Liang et al., 1998). I-Sce1 recognizes and cuts DNA at an unique 18bp 
sequence not found in the human genome (Monteilhet et al., 1990). An I-Sce1 expression 
vector is co-transfected into cells with a plasmid containing a selectable marker that will 
only express if homologous recombination occurs after I-Sce1 cleavage (Liang et al., 
1998). The level of selectable marker expression (fluorescence protein or resistance gene) 
is measured and correlates to the amount of double strand breaks repaired by homologous 
recombination (Liang et al., 1998). Coupling this technique with the knockdown of 
replication and repair proteins has identified many proteins that participate in 
homologous recombination (Johnson et al., 1999; Liang et al., 1998; Pierce et al., 1999). 
A similar system has been created to analyze nonhomologous end joining through I-Sce1 
double strand break formation (Mao et al., 2008a). However, these approaches only 
identify proteins involved in the repair of a controlled, direct double strand break 
produced by I-Sce1 cleavage. Only recently has structure induced breaks been examined. 
Carboxyterminal binding protein-interacting protein (CtIP) has been identified in the 
protection of common fragile sites and inverted repeat stability (Wang et al., 2014). This 
report used an I-Sce1 experimental design, in which a structure forming sequence was 
placed adjacent to the I-Sce1 cut site and noncanonical structure formation occurs after 
cleavage by I-Sce1 (Wang et al., 2014). In comparison, our data show FANCJ helicase is 
necessary in the prevention of structure induced double strand breaks. Additionally, the 
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structure induced breaks naturally occur in our model, unlike controlled, direct breaks 
created from I-Sce1 cleavage. Therefore, our approach offers a new method for 
identifying replication and repair proteins essential for the resolution of structure induced 
double strand breaks.      
 A large majority of next generation sequencing reads from iPCR containing 
translocation sites mapped to the endogenous c-myc locus at chr. 8q24.21. The ectopic 
site is located on chromosome 18 (Liu et al., 2003). Translocations from the ectopic site 
c-myc core replicator to the endogenous c-myc locus occurred via non-allelic 
homologous recombination. Coupled with the presence of microsatellite sequences at 
other translocation sites, we propose that repair of DSBs formed at microsatellites is 
nonrandom. However, it is possible that we are promoting nonrandom recombination 
with the presence of the c-myc core replicator at the ectopic site. Further experiments are 
underway to characterize translocations due to breaks at endogenous sites in a cell line 
void of ectopic homologous sequences. For instance, restriction digestion, ligation and 
iPCR followed by next generation sequencing of an endogenous microsatellite (i.e. 
(CTG)·(CAG) repeats of the DMPK locus or ATTCT repeats of the SCA10 locus) in 
FANCJ null cells treated with aphidicolin would be a good model. Results from these 
experiments would determine if translocations occurring from DSBs at microsatellite 
sequences show a similar propensity to repair the DSBs followed by translocation in an 
orderly fashion via a subtype of recombination, or if we have exploited the model and 
forced nonrandom recombination. Determining if the patterns of repair are different at 
endogenous sites compared to the ectopic site is the goal. Additionally, we will determine 
if the ectopic site (CTG)·(CAG) breaks induced breaks at endogenous microsatellite, or if 
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endogenous microsatellite sequences break in the absence of FANCJ during replication 
stress leaving a pool of broken DNA ends for repair by non-allelic homologous 
recombination or microhomology-mediated end joining. Nonrandom repair would result 
in translocations sites similar to the sites obtained from iPCR and NGS of the ectopic 
(CTG)·(CAG) repeats. However, if a pool of DNA ends are created as a result of 
replication stress in FANCJ null cells at microsatellite sequences and repair occurs 
through microhomology-mediated end joining, we would expect the translocations sites 
to differ between the ectopic site (CTG)·(CAG) repeats and the endogenous ATTCT 
repeats of the SCA10 locus (or any other endogenous microsatellite sequence).  
 Lastly, the next generation sequencing data presented here represents only a small 
subset of data obtained from the sequencer. The nucleotide positions of each end of the 
reads (the first nucleotide and the last nucleotide of the read) containing translocation 
junctions were used to identify the chromosome sites of translocations (as well as 
cytogenetic positions). However, the exact breakpoint junctions were not identified. 
Software exists to process deep sequencing data sets for breakpoint junctions including 
Bellerophon (Hayes and Li, 2013), and we are currently using this software to narrow the 
breakpoint junction sequences and determine whether translocation induces error-prone 
break induced replication (BIR). Recently, computer software, SVDetect (Zeitouni et al., 
2010), was created to recognize genomic variations in the sequencing data. Analysis of 
the sequencing data with Bellerophon and SVDetect, should provide insights into 
breakpoint junction locations as well as mutations that arose during the transition of 
double strand breaks to fused translocations. 
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Microsatellite stabilization by FANCJ helicase is replication dependent 
 We have shown here a novel function for FANCJ helicase in microsatellite 
stabilization during replicative stress. This novel function of FANCJ helicase is 
independent of activation of the FA repair pathway. The microsatellite sequences 
examined in this work vary in accessibility of proteins to chromatin. Some sequences are 
replicated and transcribed increasing the length of time the DNA is exposed and other 
sequences are not transcribed in HeLa cells, such as β-globin (Green et al., 1983). We 
suspect small pool PCR signal loss across genome is a function of the entire genome 
being replicated during the cell cycle supporting the notion that this novel function of 
FANCJ helicase is replication dependent and independent of other cellular processes such 
as transcription.  
Replication fork regression vs. replication fork stalling 
 Our results identify a novel function for the FANCJ helicase in microsatellite 
stabilization during replication stress. We have shown that double strand breaks form in 
cells depleted of FANCJ under replicative stress. However, when the double strand break 
occurs still remains unknown. The double strand break could form as a result of inability 
to resolve a noncanonical DNA structure (London et al., 2008) at the microsatellite 
sequence in the absence of FANCJ or through defective DNA repair mechanisms, since 
FANCJ functions in replication fork regression (Brosh, 2013; Neelsen and Lopes, 2015; 
Zellweger et al., 2015) and enables homologous recombination (Litman et al., 2005). 
Understanding the mechanisms and identifying the proteins involved in supporting 
FANCJ helicase to stabilize microsatellite sequences to protect genome stability is of 
increasing interest. We would like to deplete proteins whose functions are specific to fork 
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regression or homologous recombination in the presence of replication stress and 
examine microsatellite stability to determine the proteins functioning in signaling 
cascades necessary for FANCJ helicase to prevent microsatellite instability. 
Additionally, we propose to examine FANCJ helicase activity in replication fork 
regression and replication fork stalling via density-gradient separation of 
bromodeoxyuridine (BrdU) labelled DNA coupled with chromatin immunoprecipitation 
(ChIP). BrdU labelled DNA strands are heavier than that of unlabeled DNA strands 
(Painter and Cleaver, 1969). BrdU is incorporated into nascent DNA strands during DNA 
replication creating labelled DNA. Unlabeled DNA strands are referred to as light strands 
and BrdU labelled DNA strands are termed heavy strands. Possible combinations double 
strand DNA comprised of light strands and heavy strands have the following densities: 
light - light strand has the density of 1.716 to 1.722 g/cm
3
, heavy - light strands density 
are between 1.755 to 1.761 g/cm
3
, and heavy - heavy strands have a density between 
1.821 to 1.831 g/cm
3
 (Painter and Cleaver, 1969). Coupling BrdU labelling of DNA with 
ChIP specifies the DNA sequences of interest. Pulldown of FANCJ helicase after BrdU 
labelling would reveal only the sequences linked to FANCJ helicase (DNA sequences of 
interest) while discarding other DNA sequences. Reversal of crosslinking between DNA 
to protein, frees the DNA sequences for separation. A stalled replication fork would 
contain light-light or heavy-light DNA (Figure 63). However, replication fork regression 
occurs in response to DNA damage in which replication is reversed resulting in re-
replication of the nascent strand DNA producing heavy-heavy DNA (Figure 63). 
Comparing the composition of DNA pulled down with FANCJ during replication stress 
will provide insights into the presence of FANCJ helicase at stalled replication forks or  
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Figure 63. Proposed roles for FANCJ in replication fork stalling and 
regression. FANCJ helicase may function in either replication fork stalling or 
replication fork regression. Utilizing BrdU to label nascent strand DNA during 
replication stress with help determine which process FANCJ functions in and if 
these processes occur at microsatellite sequences. 
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regressed replication forks. For additional comparison, DNA sequences pulled down with 
BRCA2 will serve as an example for replication fork stalling, since BRCA2 has been 
shown to protect replication forks from stalling previously (Lomonosov et al., 2003; 
Schlacher et al., 2011; Ying et al., 2012). After separation of labelled and unlabeled DNA 
sequences by density, individual groups of DNA sequences (light-light, heavy-light or 
heavy-heavy) could be subjected to quantitative PCR (qPCR) to determine the abundance 
of microsatellite sequences present in each category. A greater abundance of 
microsatellite sequences in either heavy-light or heavy-heavy DNA depending on the 
process, replication fork stalling or replication fork regression respectively, disrupted in 
microsatellite instability in the absence of FANCJ helicase during replicative stress is 
expected.      
FANCJ stabilizes microsatellites independent of BLM/WRN activity 
 Current models of genome stabilization by helicases whose dysfunction leads to a 
genome instability disorder suggest a cooperative mechanism in which FANCJ unwinds 
noncanonical DNA structures in a 5’ to 3’ orientation while BLM helicase or WRN 
helicase unwind non-B form structures in a 3’ to 5’ orientation. Function of both 
direction specific helicases is necessary for proper structure resolution leading to error 
free DNA replication and repair. Knockdown of BLM helicase in (CTG)102·(CAG)102 
DM1 model cells under replication stress did not produce microsatellite instability 
suggesting the activity of BLM helicase is nonessential for FANCJ to maintain 
microsatellite stability. Similar results were obtained in BLM helicase null patient cells 
treated with either aphidicolin or hydroxyurea suggesting indeed FANCJ stabilizes 
microsatellites independently of BLM helicase activity. Furthermore, the treatment of a 
149 
 
Fanconi anemia patient cell harboring the homozygous FANCJ
R798X
 mutation eliminating 
BLM helicase interaction with aphidicolin or hydroxyurea also did not result in 
microsatellite instability further confirming BLM function remains dispensable in 
microsatellite stabilization by FANCJ helicase. 
     Knockdown of WRN helicase in (CTG)102·(CAG)102 DM1 model cells exposed 
to aphidicolin showed no instability at microsatellites indicating WRN activity is 
nonessential for FANCJ helicase to maintain chromosome stability. WRN null cells 
treated with either aphidicolin or hydroxyurea confirmed results depicting no 
microsatellite instability further confirming FANCJ helicase functions to stabilize 
microsatellites irrespective of WRN helicase activity. Considering the data presented 
regarding depletion of BLM helicase and WRN helicase, our data suggest an unique 
function for FANCJ helicase separating FANCJ from previously proposed models of 
cooperative activity with BLM helicase and WRN helicase. 
 BLM helicase and WRN helicase belong to the RecQ family of helicases along 
with RECQL4 (associated with Rothmund Thomson syndrome) (Kitao et al., 1999; 
Nakayama, 2002). Recent work has indicated redundancy exists in the function of this 
family of helicases (Sidorova et al., 2013; Sturzenegger et al., 2014). BLM helicase and 
WRN helicase function additively promotes replication fork progression (Sidorova et al., 
2013). Additionally, WRN helicase can substitute for BLM helicase during the DNA 
damage response for DNA end resection catalyzed by DNA2 (Sturzenegger et al., 2014). 
Here, we have examined the loss of BLM helicase and WRN helicase during replicative 
independently. It would be interesting to knockdown BLM helicase and WRN helicase 
simultaneously during replication stress, since these redundancies exist within the RECQ 
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family of helicases. However, we suspect no microsatellite instability would be observed 
similar to the loss of BLM helicase and WRN helicase individually. Initially, 
microsatellite stabilization during replication stress appeared to be 5’ to 3’ helicase 
specific.      
FANCJ-like family of DNA helicases  
Based on our data, we suspected microsatellite stability during replication stress 
relies on the activity of a 5’ to 3’ unwinding enzyme irrespective of 3’ to 5’ unwinding 
helicase activity. However, this work only examines the loss of FANCJ on microsatellite 
stabilization during replicative stress. A new family of helicases has emerged with 
sequence homology to FANCJ helicase (Wu et al., 2009). Helicases of this FANCJ-like 
family include XPD, ChiR1/DDX11, and RTEL1 (Wu et al., 2009). All members of this 
family of helicases share a conserved helicase core domain (Wu et al., 2009) (Figure 64). 
XPD helicase functions in nucleotide excision repair (Fan et al., 2008). ChiR1/DDX11 
helicase promotes sister chromatin cohesion (Wu et al., 2012). Lastly, the helicase 
RTEL1 helicase unwinds noncanonical DNA structures including G-quadruplexes 
formed at telomeres, is essential for trinucleotide repeat integrity, and is thought to 
promote genome stability in cancer cells through the suppression of homologous 
recombination (Barber et al., 2008; Frizzell et al., 2014; Uringa et al., 2011; Vannier et 
al., 2014). Redundancy between the functions of these helicases may exist due to 
sequence homology of the catalytic helicase domain. It is likely these helicases have 
similar function to FANCJ helicase in response to replicative stress. We suspect the loss 
of XPD, ChiR1/DDX11, or RTEL1 coupled with replication stress would lead to 
microsatellite instability as seen with the loss of FANCJ helicase. We propose that  
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Figure 64. FANCJ-like family of helicases. The FANC-like family of DNA 
helicases includes XPD, ChiR1, and RTEL1. A conserved helicase core domain is 
shared among all family members (blue bar). (Adapted from Wu et al., 2009) 
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microsatellite stabilization during replicative stress is a function of the FANCJ-like 
family of helicases. 
5’ to 3’ unwinding DNA helicases similar to FANCJ helicase 
Other 5’ to 3’ unwinding helicases that do not belong to the FANCJ-like family of 
helicases exist including Pif1 and Fbh1. Pif1 has been implicated in promoting the  
stability of G4 DNA, G-quadruplex forming DNA, at telomeres in human cells (Paeschke 
et al., 2011; Sanders, 2010). In addition, evidence exists to suggest Pif1 helicase function 
is important for resolving intermediates formed during replication and G-quadruplex 
structures formed at a guanine rich sequences at the HECT and RLD domain containing 
E3 ubiquitin protein ligase 5 (CEB1) locus (Paeschke et al., 2011; Pike et al., 2010; 
Ribeyre et al., 2009). Recent reports indicate the helicase Fbh1 localizes at DNA damage 
sites in response to accumulation of single strand DNA to promote replication fork 
regression and homologous recombination repair of DNA lesions (Chu et al., 2015; 
Fugger et al., 2009; Fugger et al., 2015). Since Pif1 and Fbh1 possess roles in DNA 
replication and repair similar to FANCJ helicase, it is possible these helicases also 
function in microsatellite stabilization during replication stress. We suspected 
microsatellite stabilization under replicative stress is a function of 5’ to 3’ DNA helicases 
who function in DNA replication or repair due to overlap in function between FANCJ 
and Pif1 or Fbh1. However, treatment of cells harboring a biallelic FANCJ
R798X
 mutation, 
which renders the protein helicase dead in vitro, with replication stressors aphidicolin or 
hydroxyurea revealed no loss of small pool PCR signal suggesting the helicase function 
of FANCJ is dispensable for microsatellite stabilization. Therefore, protection of 
microsatellite stability during replication stress is likely not a function of all 5’ to 3’  
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helicases and is specific to FANCJ helicase and possibly other members of the FANCJ-
like family of helicases.  
FANCJ
R798X
 mutant offers insights into functional domains of FANCJ  
 The most commonly occurring FANCJ mutation is R798X which produces a  
premature stop codon on the FANCJ transcript subsequently truncating the protein. This 
truncation eliminates binding sites for BRCA1, TopBP1 and BLM. Additionally, in vitro 
analysis of FANCJ
R798X
 indicated a loss of helicase activity. We examined the effect of 
truncating FANCJ by treating a Fanconi anemia complementation group J patient cell 
line harboring a homozygous FANCJ
R798X
 mutation with aphidicolin or hydroxyurea. 
Interestingly, microsatellite instability was not seen under these conditions. These results  
suggest BRCA1, TopBP1 and BLM binding or FANCJ helicase activity are not essential 
for FANCJ to maintain microsatellite stabilization. FANCJ interacts with other proteins  
necessary for DNA replication and DNA damage responses including Mre11 and the 
MRN complex (Suhasini et al., 2013), RPA (Gupta et al., 2007) and MLH1 (Peng et al., 
2007). Recently, proteins containing iron-sulfur (Fe-S) clusters are of interest. The Fe-S 
cluster of multiple proteins has been implicated in genome stability through function in 
mitochondrial respiration and DNA repair (Beilschmidt and Puccio, 2014; Paul and Lill, 
2014). FANCJ has a Fe-S cluster and this domain is essential for helicase activity (Rudolf 
et al., 2006; White, 2009). These domains, which are present in the truncated 
FANCJ
R798X
 mutant, may be essential for FANCJ to function in stabilization of 
microsatellites. 
Several groups have published on the inability to detect the FANCJ
R798X
 truncated 
mutant in vivo (Cantor and Guillemette, 2011; Litman et al., 2005). Experiments are 
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underway in our laboratory to create an epitope tagged FANCJ
R798X
 mutant protein for 
the detection of the mutant protein via Western blot, and examine its in vivo function. 
Expression of a tagged version of FANCJ
R798X
 in FANCJ null cells could be used in 
rescue experiments to determine if the domains present in the truncated protein are 
sufficient for FANCJ to stabilize microsatellites. We suspect these experiments will offer 
insights into the mechanism behind FANCJ function in promoting microsatellite stability. 
As previously stated, recombinant FANCJ
R798X
 helicase does not retain helicase activity 
in vitro. However, it is unclear if FANCJ
R798X
 helicase remains inactive in vivo. To 
confirm helicase function is dispensable for FANCJ to maintain microsatellite stability, 
mutation of lysine 52 to arginine on FANCJ (Cantor et al., 2001) could be performed. 
This residue is critical for ATPase hydrolysis and mutation leads to dysfunction of 
helicase activity (Cantor et al., 2004; Cantor et al., 2001; Gupta et al., 2005). Expression 
of FANCJ
K52R
 in FANCJ null cells under replication stress would aid in understanding 
the role the helicase domain has in microsatellite stabilization. If it is determined that the 
helicase activity of FANCJ is not essential for microsatellite stability, it is likely FANCJ 
functions as a signal for the recruitment of other repair proteins. Additionally, FANCJ-
like helicase family members who have conserved regions of homology may also 
function as a signaling molecular similar to FANCJ helicase; therefore, the loss of these 
helicases during replication stress is of interest as well. 
 As previously stated, FANCJ helicase may function in different repair processes. 
In the FA repair pathway, FANCJ utilizes interaction with BRCA1 and helicase function 
to aid DNA repair. Here, we show a second cellular process FANCJ functions in, 
microsatellite stabilization during replication stress. For microsatellite stabilization, 
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FANCJ function independent of interactions with BRCA1, TopBP1 and BLM helicase, 
activation of the FA repair pathway, and additionally, helicase activity is unessential. 
Possible mechanisms for FANCJ mediated microsatellite stabilization 
This work has not focused on a mechanism of action for FANCJ helicase in 
microsatellite stabilization. However, we have shown functional domains not essential for 
is this function of FANCJ helicase (i.e. BRCA1, TopBP1, and BLM helicase interaction). 
Therefore, we propose three possible mechanisms of action: (i) The FANCJ
R798X
 
truncation mutations of FANCJ retains interaction sites for MLH1 and interaction with 
MLH1 and other mismatch repair proteins may lead to the recruitment of FANCJ to 
microsatellite sequences. (ii) Previously published work from other researchers has 
identified interaction of Mre11 and RPA with FANCJ. However, the domains necessary 
for these interactions on FANCJ are unknown. It is possible that FANCJ is utilizing 
interaction with Mre11 or RPA for recruitment to the site of DNA damage. (iii) It is 
possible that FANCJ helicase is traveling with the replication fork during replication 
through an unknown interaction with the replisome. Recently, it was determined that 
RTEL1, a FANCJ-like helicase family member, directly interaction with proliferating cell 
nuclear antigen (PCNA) during replication and promotes proper DNA replication, 
replication stability, and telomere stability (Vannier et al., 2013). Therefore, it is possible 
FANCJ also interacts with the replisome. To understand the mechanism of action for 
FANCJ helicase in microsatellite stabilization during replication stress, these avenues 
must be examined. First, mutation of MLH1 binding domains on FANCJ would identify 
the necessity for MLH1 binding. Second, identification of Mre11 and RPA binding sites 
on FANCJ would add insight into the dependency on Mre11 and RPA interaction for 
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FANCJ to stabilize microsatellite sequences. Lastly, immunoprecipitation followed 
analysis with mass spectroscopy would determine other possible unknown interactions 
between FANCJ and other replication and repair proteins offering insights into the 
mechanism behind microsatellite stability by FANCJ helicase.      
Dog-1 as an alternate to FANCJ helicase in microsatellite stabilization    
The C. elegans orthlog of FANCJ, dog-1 (Youds et al., 2008), has previously 
been associated with the stabilization of G4 DNA sequences (thought to fold into the 
non-B form structure G-quadruplex) (Cheung et al., 2002; Kruisselbrink et al., 2008). 
Comparison of amino acid sequences of FANCJ and dog-1 revealed a conserved helicase 
domain between both proteins (Figure 65). In addition, the C-terminus of the FANCJ is 
not present in dog-1. The C-terminus includes interaction sites with BLM helicase, 
BRCA1, and TopBP1. These domains are eliminated in the truncation, R798X, mutation 
of FANCJ. Interestingly, this mutation was sufficient to protect against microsatellite 
instability. These results concur with results from experiments examining dog-1. Full 
length dog-1 (the same domains are present in the R798X mutation of FANCJ) stabilizes 
G4 DNA sequences. However, loss of dog-1, comparable to FANCJ null cells void of 
FANCJ, shows deletions of sequences flanking G4 DNA supporting the results we have 
shown confirming a role for FANCJ helicase in microsatellite stability. We hypothesize 
that expression of dog-1 in FANCJ null cells would be adequate to rescue microsatellite 
instability during replication stress. Additionally, mutation of other domains still present 
in the FANCJ
R798X
 would lead to identification of functional domains necessary for 
microsatellite stabilization.  
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Figure 65. Amino acid comparison of FANCJ and dog-1. A conserved helicase 
core domain (blue bar) is present in both human FANCJ helicase and the C. elegans 
ortholog, dog-1. (Adapted from Wu et al., 2009) 
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FANCJ helicase function in cancer 
 Recent work has identified a variety of separation of function FANCJ mutations. 
Figure 66 depicts a schematic of FANCJ mutations associated with breast cancer only, 
Fanconi anemia only, or both breast cancer and Fanconi anemia supporting distinctly 
different roles for FANCJ associated with a diverse variety of pathologies from cancer to 
developmental disorders (Cantor and Guillemette, 2011). It is likely that inability of 
FANCJ to stabilize microsatellites accompanies a subset of FANCJ mutations. 
Examining additional pathological FANCJ mutations is of interest to separate function in 
the FA repair pathway from the protection of microsatellite stability.  
FANCJ helicase as a cancer therapeutic target 
In addition to Fanconi anemia, mutation or loss of FANCJ helicase has been 
linked to susceptibility of multiple cancers including breast cancer (Cantor and 
Guillemette, 2011; De Nicolo et al., 2008; Eelen et al., 2008; Guenard et al., 2007), 
ovarian cancer (Kuusisto et al., 2011; Rafnar et al., 2011), colon cancer (Nakanishi et al., 
2012; Xie et al., 2010), and prostate cancer (Kote-Jarai et al., 2009). Multiple groups  
have referred to FANCJ helicase as a genomic caretaker and tumor suppressor (Cantor 
and Guillemette, 2011; De Nicolo et al., 2008; Peng et al., 2007; Wu et al., 2008). We 
believe our findings offer an advantageous approach to the development of new therapies 
to combat FANCJ helicase associated disorders. We suspect FANCJ helicase is a 
potential therapeutic target for the treatment of many cancers. A combinational approach 
could be developed in which FANCJ inhibition occurs during treatment with replication 
stress inducing reagents to produce genome instability. Small molecule inhibitors could 
be used to block FANCJ function followed by treatment with replication inhibitors to  
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Figure 66. Schematic of FANCJ mutations associated with disease. Mutations in 
FANCJ that are linked to breast cancer (blue), Fanconi anemia (pink) or breast 
cancer and Fanconi anemia (purple). (Adapted from Cantor and Guillementte, 2011)  
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slow the growth of tumors. Recently, a small molecule inhibitor was created to inhibit the 
activity of WRN helicase (Aggarwal et al., 2011). Treatment of HeLa cells with the small 
molecular inhibitor resulted in increased DNA damage and inhibition of cell proliferation 
(Aggarwal et al., 2011). Additionally, a recent report showed that decreased levels of 
FANCJ sensitized gastric cancer cells to oxalipalatin (platinum based chemotherapeutic) 
(Mori et al., 2013) supporting our hypothesis of combinational therapy to damage and 
ultimately destroy cancer cells. Coupling the loss of FANCJ function (through gene 
therapy or small molecule inhibitors) with a DNA damaging drug could be a novel 
therapeutic approach for the treatment of FANCJ associated cancers (breast, ovarian, 
prostate, and colon).  
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FUTURE DIRECTIONS 
 The work presented in this dissertation identifies a novel function for the FANCJ 
helicase in microsatellite stabilization during replication stress. To move forward with the 
project, we are currently creating epitope tagged expression plasmids for wild-type and 
mutant FANCJ helicase. The mutant constructs include disruption of MLH1 binding, the 
FANCJ
R798X
 mutation to determine if a truncated protein is expressed in vivo, and a 
catalytically inactive helicase domain created by a point mutation at lysine 52. The goal 
of mutagenizing FANCJ helicase focuses on determining the mechanism of action for 
FANCJ helicase in microsatellite stabilization. Additionally, we are performing 
endonuclease digestion, intramolecular ligation and inverse PCR at an endogenous 
microsatellite sequence ((CTG)19 repeats of the DMPK locus and (ATTCT)13 repeats of 
the SCA10 locus) in FANCJ null cells treated with aphidicolin. We are interested in 
understanding the mechanisms behind repair of double strand breaks at microsatellite 
sequences in cells depleted of FANCJ helicase under replicative stress. We are 
determining the phosphorylation status of checkpoint kinases including ATR, ATM, 
Chk1, and Chk2 to determine the mechanism of G2/M accumulation over time during 
aphidicolin treatment in FANCJ null cells. Lastly, we are using Bellerophon software to 
determine the exact breakpoint junctions from the inverse PCR next generation 
sequencing data. In addition, SVDetect will be used to understand the mechanisms used 
for repair and if repair occurred in an error-free process. 
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CONCLUSION 
 The work presented in this document focuses on identifying a novel function for 
the FANCJ helicase in stabilization of microsatellites. Stabilization of microsatellites by 
FANCJ occurs independently of the FA repair pathway and BLM helicase/WRN helicase 
activity. Double strand breaks form at the microsatellites resulting in translocations in 
FANCJ depleted cells during replication stress. Inverse PCR coupled with next 
generation sequencing provided a link between FANCJ function in microsatellite stability 
and a variety of cancers and developmental diseases suggesting a role for FANCJ in other 
disorders aside from Fanconi anemia. These data expand the current model of FANCJ 
function while opening a new avenue of diagnostic tool development for FANCJ 
insufficiency.  
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